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A National Assessment of the Newborn Screening Workforce
Executive Summary

The findings from this survey provide broad reinforcement to the themes expressed in the first phase
interview project conducted in the Northeast region. Overall, providers report that non-care related
time spent with patients and on education and administrative tasks is substantial and challenging.
Mentioned most frequently (64% of providers) was time spent with insurers for approvals and lacking
reimbursements for medical foods and formulas.
Patient care management and education was expressed as time consuming and often as a role taken on
by providers other than medical geneticists. Non-medical geneticists were more likely to report
spending up to four hours monthly on the phone with families, and up to four hours on non-care related
time monthly not insurance related. This becomes important in that when asked what their primary
responsibility is, most providers cited patient care, however they spent a large portion of time on noncare activities, mostly non-reimbursed.
Care coordination also varied. Most respondents cited the use of care teams, but composition of those
teams varied and roles were not understood. Less than 5% of providers cited communication with
primary care providers (PCPs) or other medical staff as primary to their responsibilities. This is despite a
majority of providers reporting that PCPs should participate in care teams but often lack knowledge of
the conditions. Others reported the need to expand care teams to ease Geneticist workload and
compensate for provider shortages. Remote patient monitoring of some kind was also mentioned by
84% of respondents, specifically to deal with geographic remoteness of patients.
Also consistently mentioned was the lack of best practices and care guidelines, especially relative to
expanding the NBS panel. While providers remain sheepishly optimistic about expansions, they also
expressed concern that the current challenges to providing care will be exacerbated.
Overall a majority of respondents report having substantial work commitments to treating patients with
metabolic disorders. Taken together, their responses reflect an uncoordinated system of care, primarily
related to extra-care activities. Care process for medically treating patients was quite consistent overall.
They are also reporting being undervalued but committed to the work of treating these patients. Many
reflected on the need to better integrate care, but lacked incentives or time to do so.
Expansions to the NBS panel will likely not be well met if many of the administrative and educational
concerns are not addressed. Further, the field of metabolic genetic medicine is not well understood by
the U.S. health care system more broadly. With reimbursement lacking and care coordination a large
part of national efforts to curb health spending, addressing the cost effectiveness of providing care to
these patients will be paramount. Developing more consistent and effective care teams and care
process guidelines should be investigated. This will include consistent measuring of care coordination
time and effort to maximize reimbursement from insurers.
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A National Assessment of the Newborn Screening Workforce

Overview
This study proposed to assess the scope and intensity of services needed to provide quality
genetic health care to newborns diagnosed with metabolic conditions following a positive newborn
screen (NBS) from birth to age one across the United States. The resources examined included time
spent on face-to-face visits as well as non-visit time for health care providers treating these patients.
The term ‘health care providers’ was broadly defined to include any person who works with the patient
in an official health care capacity including clinical geneticists, dietitians/nutritionists, genetic
counselors, patient advocates, and office/administrative staff. Previous work on this topic in the New
England region has shown that providing care to patients with metabolic conditions requires frequent
visits and many non-visit hours of work. 19 Additionally, providers often take on responsibilities that are
tangential to their official duties, for example, dietitians often act as care coordinators for their patients
and families. This project was designed based on the work in the New England region to determine if
these patterns were evident nationally.

Background and Rationale
Newborn screening (NBS) is a state-based universally mandated core public health function that
identifies the presence of specific disorders at birth so that treatment can begin before clinical
symptoms present, often mitigating adverse health outcomes or death. Most of these conditions are
inborn errors of metabolism, and therefore genetic. With improved technologies the number of
metabolic conditions tested on the NBS panel continues to expand. However, these expansions
highlight three pervasive issues within the current medical genetics workforce: (1) the workforce is
inadequate to meet current demand for genetics services; (2) the metabolic conditions screened for on
the NBS panel often require high intensity management; and (3) most are rare diagnoses requiring
coordinated specialty care.
Researchers studying the medical genetics workforce have concluded that the size of the
current clinical genetics workforce1,2 and the number of students entering the field2,3 are inadequate to
meet the growing demand for genetic services. Clinical geneticists are poorly dispersed across states1
and a high proportion of geneticists practice in urban areas and academic medical centers,1,4, 5, 6 that are
not accessible to large portions of the population who need services but live a distance away. Clinical
geneticists often work with a team of health care providers, including genetic counselors, whose
workforce issues must also be addressed and understood.1,4,5,7,8
One commonly cited reason for problems within the medical genetics workforce relates to
income and reimbursement. Reimbursement rates for genetic services are poor1,7 and clinical
geneticists report low satisfaction with income and earning potential despite the fact that many clinical
geneticists are reporting increases in patient volume1,5 and complexity.1 Combined with high levels of
labor intensity and job-related stress, beginning a career in medical genetics is reported to be less
attractive to future practitioners at a time when the demand for genetic services is growing. 1,2,9
Workforce capacity is an especially salient issue for NBS because of the intensity of treatment.
Visits for new and follow-up patients at genetics clinics for the metabolic conditions on the panel are
lengthy, averaging 40 to 65 minutes.1,5 Genetics providers also spend substantial amounts of time on
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patient care activities outside of the clinic visit: approximately three hours on average for new patient
visits and two additional hours for follow-up visits.4,9, 10
The labor intensity of diagnosing and treating conditions detected on NBS is counterbalanced by
two issues. First, according to published research, approximately 2.4 of every 1,000 live births resulted
in the detection of a condition identified on NBS in the U.S. in 2010.11 Very few children actually need
treatment; thus, it is difficult to estimate the size of the workforce needed to treat these conditions.12
Second, while more conditions that have severe health and developmental consequences can be
detected by tandem mass spectrometry, 13, 14 there is little to no information about the treatment or
natural course of many of these conditions.9,15, 16, 17 In particular, Steiner reports that there is little
evidence-base on the treatment of inborn errors of metabolism because there are few research
subjects, most of these diagnoses are made at birth, and treatments may need to be individualized to
patient-specific characteristics.15 Additionally, a national infrastructure for collecting this information
was only recently developed (the NBS Translational Research Network (NBSTRN)).18
Finally, the growth of genetic medicine is changing the relationships between primary care
providers, geneticists, and patients. Relationships between genetic specialists and primary care
providers would seem especially important for patients who screen positive for a metabolic condition on
NBS.8 Yet studies have found that most primary care providers’ knowledge about genetics remains
inadequate.6-8, 17
NBS brings to the forefront the tenuous balance between the adequacy of the medical genetics
workforce and the rare yet labor-intensive conditions screened for on the NBS panel.
Because research to date has not directly studied the workforce needed to care for children
diagnosed with a metabolic condition during NBS, a first phase of empirical study into this issue was
conducted by the New England Genetics Collaborative at the University of New Hampshire for the NCC
to examine issues of care resources being utilized for metabolic patients, as well as extra-care activities
such as education with families, administrative tasks, and care coordination between providers.19 That
study examined the process of care for children with a positive metabolic newborn screen through
expert interviews with providers across the New England Region. Findings suggested that the NBS
process worked well in the states, but that resource intensity varied markedly depending on the
condition with which the child was diagnosed. Also found was that care coordination was lacking both
between treating providers and primary care providers and the metabolic team, and that the roles of
care teams were often diverse and not well understood or communicated. Educational and
administrative burden was also found to be substantial. Many providers believed that while there is
potentially great promise from enhanced metabolic screening, the workload and process issues that
currently exist would be exacerbated.19
These findings provide an important empirical window into the care process for metabolic
patients broadly defined. It was, however, conducted on a limited geographic sample of providers in the
Northeast. Further data collection was warranted to understand if similar issues were being
experienced in other parts of the country. For this reason, a larger national survey was developed as a
second phase of this work, informed from the findings of the first.
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Methodology
Similar to phase one, the phase two survey sought to define the process of care for newborns
diagnosed with metabolic conditions after positive newborn screens (NBS) from birth to age one based
on reports from a national sample of health care providers who treat such patients. Metabolic
conditions were selected because they provide a more definable treatment protocol than some other
disorders on the NBS panel and thus allow for more accurate empirical measurement of the resources
needed to treat those patients. Additionally, it examined the amount of time that providers spent
working on these patients’ cases outside of visit time, potential challenges to providing care, and
attitudes about an expanded NBS panel. These topics were defined based on the phase one interview
project conducted during 2010.
In order to assess these factors at the national level, an online survey was created. In addition
to the phase one findings, input into the survey was sought from the regional collaboratives nationwide.
Those in the West and Midwest cited the use of telemedicine and access as additional areas of interest
for inclusion in the survey. The final tool, found in Appendix A, contained seventy-four questions and
was deployed by the University of New Hampshire Survey Center. The survey opened on September 28,
2011 and closed on May 1, 2012. Participants were recruited in two stages. First, potential participants
were contacted through the Regional Genetic and Newborn Screening Service Collaboratives. Second,
participants were recruited via professional organizations, conferences, and networks. Potential
participants were contacted electronically by the National Coordinating Center for the Regional Genetic
and Newborn Screening Service Collaboratives (NCC), the Society for Inherited Metabolic Disorders
(SIMD), the NBS mailing list (Newborn Screening Inquiry/Discussion List) by Dr. Brad Therrell
(NBS@lists.UTSCSA.edu), and the Pediatric and Clinical Genetics special interest group listserv of the
National Society of Genetic Counselors (NSGC). Finally, the survey was made available electronically and
in paper format at the American College of Medical Genetics (ACMG) Annual Clinical Genetics Meetings
(March 27-31, 2012) and the Genetic Metabolic Dietitians International (GMDI) Educational Conference
(April 19-21, 2012). The sampling methodology is detailed in Appendix B.
Analyses were conducted using Stata 11. The analyses created for this report are based on the
114 usable surveys that were submitted. Sample sizes vary for each section of the survey because of
skip patterns and missing data; respondents who responded to at least one question in a given section
were included in that section’s analysis. The final sample contained 67 clinical geneticists and 47 other
(non-clinical geneticist) providers. Process of care and non-visit administrative time analyses were
calculated separately for clinical geneticists and all other providers. Significance tests were not
calculated because of thin cells. Providers were invited to write-in comments about ‘best practices’ and
other concerns not covered by the survey at the end of the survey. These comments have been coded
thematically and incorporated with statistical findings.
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Summary of Findings
The sections below represent a summary of the key findings from each area of the survey.
Detailed analyses are presented in the following section.
Care Process
The intensity of services provided to newborns with metabolic conditions detected on NBS can be
described by the frequency, length, and duration of contact between patients/families and providers.
o Providers are in contact – via telephone and face-to-face visits – with patients and their families
very soon after a metabolic condition is detected on NBS.
o Providers are in contact with patients frequently during the first year of life. Although metabolic
disorders vary, providers seem to have frequent contact with patients who have any type of
metabolic disorder.
o Providers see patients less frequently as patients get older during the first year of life.
Clinical geneticists and other providers have similar rates of contact with providers for most disorder
categories. However, for some metabolic conditions, for example, amino acid disorders, other providers
reported more frequent visits with patients/families than did clinical geneticists.
Non-Visit Administrative Time
Administrative tasks, such as talking on the phone with families, doing case management, interacting
with insurance companies, and preparing for face-to-face visits, were reported as time-consuming tasks.
Differences were evident by provider type: other providers more frequently reported spending more
time on the phone with families, doing case management, preparing for face-to-face visits, working with
insurance companies, and on other tasks than did clinical geneticists.
The most time-intensive reasons that providers reported were related to insurance; specifically
approvals for medical foods and formulas, approvals for medications, and general reimbursement for
services.
Care Coordination and Models of Care Provision
Providers reported many responsibilities for patients. Providers most frequently reported being
responsible for managing medical needs and educating patients and families. Other providers
frequently reported coordinating care for patients and families.
Different models of care provision were used by providers’ clinics to address patient needs; most
important was using a team approach to care. Providers also frequently reported using satellite clinics
and using telemedicine technologies.
Challenges to Providing Care
Practitioners reported that their ability to provide care during the first year of life is primarily made
challenging by the lack of reimbursement for patient care. Other factors, such as parental/familial
knowledge and awareness of the disorder, compliance with treatment and management protocols were
considered somewhat challenging.
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However, some factors were considered less challenging. Specifically, providers’ contact with state NBS
or follow-up programs, the ability to transition patients to hospital providers, and the practitioners’ own
educational needs concerning metabolic disorders were not considered challenging.
Education
Providers reported spending substantial amounts of time educating families about metabolic conditions.
Families needed to be educated about the treatment and management of the disorders in addition to
other basic information.
Providers mainly used pamphlets, resource binders, and websites to educate their patients and families.
Families, providers reported, only sometimes had accurate information about metabolic disorders when
they came into the provider’s practice.
Relationships with Primary Care Providers
Metabolic providers reported that relationships with primary care providers were important and that
primary care providers should participate in the care of patients with metabolic conditions, despite what
was perceived as a lack of knowledge about these conditions.
Attitudes about Expanding the Newborn Screening Panel
Providers seemed cautiously optimistic about expanding the NBS panel. While they were excited to
treat children whose conditions would otherwise go undetected, they remain concerned about the
number of trained providers, the ability to spend enough time with new patients, and about being
reimbursed for care provided.

Detailed Analysis and Findings
Detailed analytic findings are presented below. They have been divided topically for clarity.
Sample sizes for analyses are indicated.
1. Sample
The final sample contained a total of 114 cases with usable data, as shown in Table 1. The
majority of respondents were clinical geneticists (59%). Because one of the goals of this project was to
assess processes of care for all providers, the sample was divided based on provider type: clinical
geneticists versus all other providers. The majority of other providers were dietitians/nutritionists
(38%), genetic counselors (21%), and ‘other’ providers (21%). These ‘other’ providers include nurse
practitioners, neurologists, and lab directors, among others.
The majority of providers (60%) stated that less than 40% of their practice was dedicated to
treating children diagnosed with metabolic conditions following a positive NBS from birth to age one.
Eleven percent reported that at least 90% of their practice was composed of these children. Nearly twothirds of clinical geneticists (63%) reported that less than 30% of their practice was composed of these
children, compared to 28% of other providers. Other providers were most likely (26%) to report that at
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least 90% of their practice was dedicated to treating children diagnosed with metabolic conditions
following a positive NBS.
At least 90% of all providers reported treating children with each of the three types of metabolic
disorders on the NBS panel – organic acid disorders (90%), fatty acid oxidation disorders (94%), amino
acid disorders (93%). Eighty-nine percent of all providers reported treating children with all of these
types of disorders. Clinical geneticists were most likely to report that they treated children with fatty
acid oxidation disorders (97%), while other providers were most likely to report that they treated
children with amino acid disorders (92%).
Respondents were asked to provide their zip code so that processes of care could be assessed
regionally. Most providers (33%) did not report their zip codes and could thus not be assigned to a
region. However, providers who were able to be assigned to a region were spread rather evenly across
the United States. This remained consistent for clinical geneticists and other providers.
1

Table 1. Respondent Characteristics

Provider Type
Total Sample
(n=114)

Clinical Geneticists
(n=67)

Other Providers
(n=47)

Clinical Geneticist

58.77% (67)

100% (67)

-

Dietitian/Nutritionist

15.79 (18)

-

38.30 (18)

Social Worker

0.88 (1)

-

2.13 (1)

Nurse

2.65 (3)

-

6.38 (3)

Patient Advocate

0.88 (1)

-

2.13 (1)

Office/Administrative Manager

2.63 (3)

-

6.38 (3)

Genetic Counselor

8.77 (10)

-

21.28 (10)

Primary Care Provider

0.88 (1)

-

2.13 (1)

8.77 (10)

-

21.28 (10)

0-10%

12.28 (14)

17.91 (12)

4.26 (2)

11-20%

21.05 (24)

23.88 (16)

17.02 (8)

21-30%

14.91 (17)

20.90 (14)

6.38 (3)

31-40%

11.40 (13)

11.94 (8)

10.64 (5)

41-50%

6.14 (7)

5.97 (4)

6.38 (3)

51-60%

7.02 (8)

7.46 (5)

6.38 (3)

61-70%

4.39 (5)

5.97 (4)

2.13 (1)

71-80%

1.75 (2)

1.49 (1)

2.13 (1)

81-90%

4.39 (5)

1.49 (1)

8.51 (4)

91-100%

11.40 (13)

1.49 (1)

25.53 (12)

Not Reported

5.26 (6)

1.49 (1)

10.64 (5)

Organic Acid Disorders

90.35 (103)

94.03 (63)

85.11 (40)

Fatty Acid Oxidation Disorders

93.86 (107)

97.01 (65)

89.36 (42)

Amino Acid Disorders

92.98 (106)

94.03 (63)

91.49 (43)

Provider Type #1

Other
Percentage of Practice Dedicated to These Children

Providers Treat Children Diagnosed with…

U.S. Census Region
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Northeast

17.54 (20)

17.91 (12)

17.02 (8)

South

17.54 (20)

17.91 (12)

17.02 (8)

Midwest

14.04 (16)

10.45 (7)

19.15 (9)

West

18.42 (21)

19.40 (13)

17.02 (8)

Not Reported

32.46 (37)

34.33 (23)

29.79 (14)

1

Column percentages are shown.

2. Processes of Care
In order to assess the scope and intensity of services provided to patients, this project
distinguished between three categories of metabolic disorders: organic acid disorders, fatty acid
oxidation disorders, and amino acid disorders. While there is substantial variation within each category
of disorder, these categories serve to identify the different disorders and treatment protocols
appropriate to each type of disorder. Additionally, as one provider stated in the Best Practices section
of the survey, processes of care vary by “unique factors (insurance, level of education/understanding,
geographic location, etc.)” it can be difficult to “generalize a specific plan to all patients.” The following
analyses identify the disorder category and associated process of care. For each category of disorder,
providers were asked to indicate the individual disorders they saw most commonly in their practice and
the length and frequency of initial and follow-up visits and phone calls.
Organic Acid Disorders
Among the 103 respondents who reported that they treated children diagnosed with organic
acid disorders following positive NBS, only 94 answered any questions regarding the specific conditions
they saw or services they provided. The results presented below reflect the reports of those 94
respondents.
As shown in Table 2a, the most frequently reported organic acid disorders seen in practice were
Priopionic Academia (PROP; 66%) and Methylmalonic Acidemia (Methylmalonyl-CoA Mutase) (MUT;
62%). Providers also frequently reported 3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC; 42%),
Glutaric Acidemia Type I (GA1; 40%), and Methylmalonic Acidemia (Cobalamin Disorders) (Cbl, A, B;
37%). This pattern remained the same for clinical geneticists. Among other providers, Propionic
Acidemia (PROP; 68%) was the most frequently reported disorder, followed by Methylmalonic Acidemia
(Methylmalonyl-CoA Mutase) (MUT; 50%) and Isovaleric Acidemia (IVA; 42%).
Table 2a. Organic Acid Disorders Most Often Seen in Practice
Total
(n=94)

Provider Type
Clinical Geneticists Other Providers
(n=56)
(n=38)

Propionic Academia (PROP)

65.96 (62)

64.29 (36)

68.42 (26)

Methylmalonic Acidemia (Methylmalonyl-CoA Mutase) (MUT)

61.70 (58)

69.64 (39)

50.00 (19)

Methylmalonic Acidemia (Cobalamin Disorders) (Cbl, A, B)

37.23 (35)

37.50 (21)

36.84 (14)

Isovaleric Acidemia (IVA)

29.79 (28)

21.43 (12)

42.11 (16)

3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC)

41.49 (39)

42.86 (24)

39.47 (15)

3-Hydroxy-3-Methyglutaric Aciduria (HMG)

2.13 (2)

3.57 (2)

0.00 (0)

Holocarboxylase Synthase Deficiency (MCD)

3.19 (3)

3.57 (2)

2.63 (1)
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B-Ketothiolase Deficiency (BKT)

3.19 (3)

1.79 (1)

5.26 (2)

Glutaric Acidemia Type I (GA1)

40.43 (38)

44.64 (25)

35.21 (13)

Table 2b contains providers’ reports of the frequency, timing, and duration of visits for children
diagnosed with organic acid disorders during the first year of life. More than half of providers reported
talking to the patient’s family on the phone the same day or day after a positive NBS. An additional 30%
make this phone call within one week of the detection of an organic acid disorder. While most clinical
geneticists and other providers reported talking on the phone with patients’ families within one week,
clinical geneticists were more likely than other providers to report that this first phone call occurred the
day of or day after positive NBS. This first phone call usually lasts less than one hour (88%).
The first patient visit was also reported to occur quickly. Thirty percent of providers reported
seeing patients with positive NBS the same day or the day after an abnormal NBS; an additional 45%
reported seeing patients within one week of the abnormal blood result. Clinical geneticists more
frequently reported seeing patients sooner (within the week) than other providers, who were most
likely to report seeing patients within two weeks (68%) of the abnormal blood result. This first visit was
lengthy. More than 75% of providers reported that the first visit lasted between one and two hours; an
additional 17% reported that it lasted between two and four hours. The length of the first visit was
similar among clinical geneticists and other providers.
After these initial contacts, patients were seen less frequently by providers over the course of
the first year of life. During the first month, approximately 60% of providers reported seeing patients
between weekly and a few times per month. During months two and three, patients were reported to
visit providers between a few times a month (27%) and once a month (37%). During months four
through six, providers reported that they saw patients between once a month (37%) and once every
couple of months (45%). Finally, during months seven through twelve, 75% of providers reported that
they saw patients with organic acid disorders every couple of months. These follow-up visits were also
lengthy. Approximately 70% of providers reported that these visits lasted between 30 minutes and 1
hour. The reported frequency and duration of follow-up visits was similar for clinical geneticists and
other providers.
Table 2b. Process of Care for Children Treated for Organic Acid Disorders

1

Provider Type
Total (n=94)

Clinical Geneticists
(n=56)

Other Providers
(n=38)

First Phone Call
The Same or Next Day

52.13 (49)

66.07 (37)

31.58 (12)

Within the Week

28.72 (27)

19.64 (11)

42.11 (16)

Within Two Weeks

7.45 (7)

3.57 (2)

13.16 (5)

Within the Month

5.32 (5)

5.36 (3)

5.26 (2)

Within Six Months

1.06 (1)

0.00 (0)

2.63 (1)

Not Reported

5.32 (5)

5.36 (3)

5.26 (2)

Less than 1 Hour

88.30 (83)

83.93 (47)

94.74 (36)

1-2 Hours

6.38 (6)

10.71 (6)

0.00 (0)

Not Reported

5.32 (5)

5.36 (3)

5.26 (2)

Length of First Phone Call

First Patient Visit
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The Same or Next Day

29.79 (28)

37.50 (21)

18.42 (7)

Within the Week

44.68 (42)

47.43 (26)

42.11 (16)

Within Two Weeks

17.02 (16)

10.71 (6)

26.32 (10)

Within the Month

5.32 (5)

3.57 (2)

7.89 (3)

Within Six Months

1.06 (1)

0.00 (0)

2.63 (1)

Not Reported

2.13 (2)

1.79 (1)

2.63 (1)

Less than 1 Hour

4.26 (4)

5.36 (3)

2.63 (1)

1-2 Hours

76.60 (72)

75.00 (42)

78.95 (30)

2-4 Hours

17.02 (16)

17.86 (10)

15.79 (6)

Not Reported

2.13 (2)

1.79 (1)

2.63 (1)

More than Once a Week

3.19 (3)

3.57 (2)

2.63 (1)

Once a Week

30.85 (29)

32.14 (18)

28.95 (11)

2-3 Times per Month

31.91 (30)

30.36 (17)

34.21 (13)

Once a Month

22.34 (21)

26.79 (15)

15.79 (6)

Every Couple of Months

5.32 (5)

5.36 (3)

5.26 (2)

Never

3.19 (3)

0.00 (0)

7.89 (3)

Not Reported

3.19 (3)

1.79 (1)

5.26 (2)

Once a Week

5.32 (5)

3.57 (2)

7.89 (3)

2-3 Times per Month

26.60 (25)

23.21 (13)

31.58 (12)

Once a Month

37.23 (35)

42.86 (24)

28.95 (11)

Every Couple of Months

21.28 (20)

21.43 (12)

21.05 (8)

Never

2.13 (2)

0.00 (0)

5.26 (2)

Not Reported

7.45 (7)

8.93 (5)

5.26 (2)

2-3 Times per Month

11.70 (11)

8.93 (5)

15.79 (6)

Once a Month

37.23 (35)

39.29 (22)

34.21 (13)

Every Couple of Months

44.68 (42)

46.43 (26)

42.11 (16)

Not Reported

6.38 (6)

5.36 (3)

7.89 (3)

2-3 Times per Month

2.13 (2)

1.79 (1)

2.63 (1)

Once a Month

17.02 (16)

12.50 (7)

23.68 (9)

Every Couple of Months

74.47 (70)

80.36 (45)

65.79 (25)

Not Reported

6.38 (6)

5.36 (3)

7.89 (3)

15-30 Minutes

12.77 (12)

16.07 (9)

7.89 (3)

30-45 Minutes

40.43 (38)

33.93 (19)

50.00 (19)

45 Minutes-1 Hour

28.72 (27)

28.57 (16)

28.95 (11)

More than 1 Hour

15.96 (15)

19.64 (11)

10.53 (4)

Not Reported

2.13 (2)

1.79 (1)

2.63 (1)

Length of First Visit

Frequency of Follow-Up Visits
First Month

Months 2-3

Months 4-6

Months 7-12

Length of Follow-Up Visits
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1

Column percentages are shown.

Fatty Acid Oxidation Disorders
Among the 107 respondents who reported that they treated children diagnosed with fatty acid
oxidation disorders following positive NBS, only 92 answered any questions regarding the specific
conditions they saw or services they provided. The results presented below reflect the reports of those
92 respondents.
As shown in Table 2c, the most frequently reported fatty acid oxidation disorders were MediumChain Acyl-CoA Dehydrogenase Deficiency (MCAD; 94%) and Very Long-Chain Acyl-CoA Dehydrogenase
Deficiency (VLCAD; 85%). These were also the most commonly reported conditions for clinical
geneticists and other providers.
Table 2c. Fatty Acid Oxidation Disorders Most Often Seen in Practice
Provider Type
Total
(n=92)

Clinical Geneticists
(n=54)

Other Providers
(n=38)

Carnitine Uptake Defect/Carnitine Transport Defect (CUD)

50.00 (46)

61.11 (33)

34.21 (13)

Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)

93.48 (86)

96.30 (52)

89.47 (34)

Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)

84.78 (78)

83.33 (45)

86.84 (33)

Long-Chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)

34.78 (32)

31.48 (17)

39.47 (15)

Trifunctional Protein Deficiency (TFP)

6.52 (6)

3.70 (2)

10.53 (4)

Table 2d contains providers’ reports of the frequency, timing, and duration of visits for children
diagnosed with fatty acid oxidation disorders during the first year of life. Nearly half of providers
reported talking to the patient’s family on the phone the same day or day after a positive NBS. An
additional 33% make this phone call within one week of the detection of a fatty acid oxidation disorder.
While most clinical geneticists and other providers reported talking on the phone with patients’ families
within one week, clinical geneticists were more likely than other providers to report that this first phone
call occurred the day of or day after positive NBS. This first phone call usually lasts less than one hour
(84%); this was similar for clinical geneticists and other providers.
The first patient visit was also reported to occur quickly. Twenty percent of providers reported
seeing patients with positive NBS the same day or the day after an abnormal NBS; 46% reported seeing
patients within one week of the abnormal blood result; and 26% reported seeing patients within two
weeks. The timing of this first visit was similar for clinical geneticists and other providers. This first visit
was lengthy. Eighty percent of providers reported that the first visit lasted between one and two hours;
an additional 11% reported that it lasted between two and four hours. The length of the first visit was
similar among clinical geneticists and other providers.
After these initial contacts, patients were seen less frequently by providers over the course of
the first year of life. During the first month, approximately 40% of providers reported seeing patients
once a month. During months two and three, patients were reported to visit providers between once a
month (32%) and every couple of months (37%). Between months 4 and 12, most providers reported
that they saw patients once every couple of months. Most providers (41%) reported that follow-up
visits lasted between 30 and 45 minutes, and an additional 30% reported follow-up visits lasting 45
minutes to 1 hour. The reported frequency and duration of follow-up visits was similar for clinical
geneticists and other providers.
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Table 2d. Process of Care for Children Treated for Fatty Acid Oxidation Disorders

1

Provider Type
Total
(n=92)

Clinical Geneticists
(n=54)

Other Providers
(n=38)

First Phone Call
The Same or Next Day

47.83 (44)

61.11 (33)

28.95 (11)

Within the Week

32.61 (30)

25.93 (14)

42.11 (16)

Within Two Weeks

8.70 (8)

5.56 (3)

13.16 (5)

Within the Month

5.43 (5)

1.85 (1)

10.53 (4)

Not Reported

5.43 (5)

5.56 (3)

5.26 (2)

Less than 1 Hour

83.70 (77)

81.48 (44)

89.84 (33)

1-2 Hours

9.78 (9)

12.96 (7)

5.26 (2)

Not Reported

6.52 (6)

5.56 (3)

7.89 (3)

The Same or Next Day

19.57 (18)

22.22 (12)

15.79 (6)

Within the Week

45.65 (42)

48.15 (26)

42.11 (16)

Within Two Weeks

26.09 (24)

24.07 (13)

28.95 (11)

Within the Month

5.43 (5)

3.70 (2)

7.89 (3)

Not Reported

3.26 (3)

1.85 (1)

5.26 (2)

Less than 1 Hour

5.43 (5)

7.41 (4)

2.63 (1)

1-2 Hours

80.43 (74)

77.78 (42)

84.21 (32)

2-4 Hours

10.87 (10)

12.96 (7)

7.89 (3)

Not Reported

3.26 (3)

1.85 (1)

5.26 (2)

More than Once a Week

4.35 (4)

3.70 (2)

5.26 (2)

Once a Week

18.48 (17)

22.22 (12)

13.16 (5)

2-3 Times per Month

21.74 (20)

18.52 (10)

26.32 (10)

Once a Month

40.22 (37)

46.30 (25)

31.58 (12)

Every Couple of Months

9.78 (9)

7.41 (4)

13.16 (5)

Never

1.09 (1)

0.00 (0)

2.63 (1)

Not Reported

4.35 (4)

1.85 (1)

7.89 (3)

Once a Week

4.35 (4)

3.70 (2)

5.26 (2)

2-3 Times per Month

15.22 (14)

16.67 (9)

13.16 (5)

Once a Month

31.52 (29)

29.63 (16)

34.21 (13)

Every Couple of Months

36.96 (34)

40.74 (22)

31.58 (12)

Not Reported

11.96 (11)

9.26 (5)

15.79 (6)

5.43 (5)

7.41 (4)

2.63 (1)

Length of First Phone Call

First Patient Visit

Length of First Visit

Frequency of Follow-Up Visits
First Month

Months 2-3

Months 4-6
2-3 Times per Month
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Once a Month

29.35 (27)

25.93 (14)

34.21 (13)

Every Couple of Months

58.70 (54)

61.11 (33)

55.26 (21)

Not Reported

6.52 (6)

5.56 (3)

7.89 (3)

2-3 Times per Month

1.09 (1)

1.85 (1)

0.00 (0)

Once a Month

7.61 (7)

5.56 (3)

10.53 (4)

Every Couple of Months

84.78 (78)

87.04 (47)

81.58 (31)

Not Reported

6.52 (6)

5.56 (3)

7.89 (3)

15-30 Minutes

10.87 (10)

9.26 (5)

13.16 (5)

30-45 Minutes

41.30 (38)

35.19 (19)

50.00 (19)

45 Minutes-1 Hour

30.43 (28)

33.33 (18)

26.32 (10)

More than 1 Hour

13.04 (12)

16.67 (9)

7.89 (3)

Not Reported

4.35 (4)

5.56 (3)

2.63 (1)

Months 7-12

Length of Follow-Up Visits

1

Column percentages are shown.

Amino Acid Disorders
Among the 106 respondents who reported that they treated children diagnosed with amino acid
disorders following positive NBS, only 89 answered any questions regarding the specific conditions they
saw or services they provided. The results presented below reflect the reports of those 89 respondents.
As shown in Table 2e, the most frequently reported amino acid disorder was Classic
Phenylketonuria (PKU; 94%). Nearly half of providers also reported frequently treating children with
Maple Syrup Urine Disease (MSUD). These findings were similar for clinical geneticists and other
providers.
Table 2e. Amino Acid Disorders Most Often Seen in Practice
Provider Type
Total
(n=89)

Clinical Geneticists
(n=51)

Other Providers
(n=38)

Argininosuccinic Aciduria (ASA)

39.33 (35)

41.18 (21)

36.84 (14)

Citrullinemia, Type I (CIT)

38.20 (34)

43.14 (22)

31.58 (12)

Maple Syrup Urine Disease (MSUD)

49.44 (44)

50.98 (26)

47.37 (18)

Homocystinuria (HCY)

34.83 (31)

33.33 (17)

36.84 (14)

Classic Phenylketonuria (PKU)

94.38 (84)

96.08 (49)

92.11 (35)

Tyrosinemia, Type I (TYR I)

14.61 (13)

13.73 (7)

15.79 (6)

Table 2f contains providers’ reports of the frequency, timing, and duration of visits for children
diagnosed with amino acid disorders during the first year of life. Sixty-three percent of providers
reported talking to the patient’s family on the phone the same day or day after a positive NBS. An
additional 18% make this phone call within one week of the detection of an amino acid disorder. Most
clinical geneticists reported talking on the phone with patients’ families the day of or after an amino acid
disorder was detected; among other providers, 45% reported talking to patients’ families the same or
next day and 29% reported talking to families within a week of the condition’s detection. This first
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phone call usually lasts less than one hour (80%); this was similar for clinical geneticists and other
providers.
The first patient visit was also reported to occur quickly. Thirty-seven percent of providers
reported seeing patients with positive NBS the same day or the day after an abnormal NBS and an
additional 44% reported seeing patients within one week of the abnormal blood result. Fifty-one
percent of clinical geneticists reported seeing the patient for the first time the same or next day; an
additional 39% reported seeing the patient within one week of the abnormal NBS. Other providers saw
patients less quickly; 21% of other providers saw patients within two weeks of the detection of the
amino acid disorder. This first visit was lengthy. Seventy-three percent of providers reported that the
first visit lasted between one and two hours; an additional 21% reported that it lasted between two and
four hours. The length of the first visit was similar among clinical geneticists and other providers.
After these initial contacts, patients were seen less frequently by providers over the course of
the first year of life. During the first three months, providers reported seeing patients once a month.
Between months 4 and 12, most providers reported that they saw patients once every couple of
months. The timing of visits differed between clinical geneticists and other providers. While most
clinical geneticists reported seeing patients once a week during the first month, (41%), once a month
during months two through three (37%), and every couple of months during months four through 12,
other providers reported seeing patients more frequently. During the first month, other providers
reported seeing patients between once a week (29%) and a few times per month (32%). Other
providers also frequently reported seeing patients a few times a month (32%) during months two and
three and between once a month (37%) and every couple of months (40%) during months four through
six. During months seven through twelve, other providers most frequently reported seeing patients
every couple of months (66%). Most providers (46%) reported that follow-up visits lasted between 30
and 45 minutes, and an additional 29% reported follow-up visits lasting 45 minutes to 1 hour. The
reported duration of follow-up visits was similar for clinical geneticists and other providers.
1

Table 2f. Process of Care for Children Treated for Amino Acid Disorders

Provider Type
Total
(n=89)

Clinical Geneticists
(n=51)

Other Providers
(n=38)

First Phone Call
The Same or Next Day

62.92 (56)

76.47 (39)

44.74 (17)

Within the Week

17.98 (16)

9.80 (5)

28.95 (11)

Within Two Weeks

11.24 (10)

7.84 (4)

15.79 (6)

Within the Month

2.25 (2)

1.96 (1)

2.63 (1)

Not Reported

5.62 (5)

3.92 (2)

7.89 (3)

Less than 1 Hour

79.78 (71)

78.43 (40)

81.58 (31)

1-2 Hours

14.61 (13)

17.65 (9)

10.53 (4)

Not Reported

5.62 (5)

3.92 (2)

7.89 (3)

The Same or Next Day

37.08 (33)

50.98 (26)

18.42 (7)

Within the Week

43.82 (39)

39.22 (20)

50.00 (19)

Within Two Weeks

14.61 (13)

9.80 (5)

21.05 (8)

Within the Month

2.25 (2)

0.00 (0)

5.26 (2)

Length of First Phone Call

First Patient Visit
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Within Six Months

1.12 (1)

0.00 (0)

2.63 (1)

Not Reported

1.12 (1)

0.00 (0)

2.63 (1)

Less than 1 Hour

4.49 (4)

5.88 (3)

2.63 (1)

1-2 Hours

73.03 (65)

72.55 (37)

73.68 (28)

2-4 Hours

21.35 (19)

21.57 (11)

21.05 (8)

Not Reported

1.12 (1)

0.00 (0)

2.63 (1)

More than Once a Week

5.62 (5)

3.92 (2)

7.89 (3)

Once a Week

35.96 (32)

41.18 (21)

28.95 (11)

2-3 Times per Month

25.84 (23)

21.57 (11)

31.58 (12)

Once a Month

23.60 (21)

29.41 (15)

15.79 (6)

Every Couple of Months

4.49 (4)

3.92 (2)

5.26 (2)

Never

2.25 (2)

0.00 (0)

5.26 (2)

Not Reported

2.25 (2)

0.00 (0)

5.26 (2)

Once a Week

11.24 (10)

9.80 (5)

13.16 (5)

2-3 Times per Month

26.97 (24)

23.53 (12)

31.58 (12)

Once a Month

32.58 (29)

37.25 (19)

26.32 (10)

Every Couple of Months

19.10 (17)

19.61 (10)

18.42 (7)

Never

2.25 (2)

0.00 (0)

5.26 (2)

Not Reported

7.87 (7)

9.80 (5)

5.26 (2)

Once a Week

3.37 (3)

3.92 (2)

2.63 (1)

2-3 Times per Month

16.85 (15)

19.61 (10)

13.16 (5)

Once a Month

32.58 (29)

29.41 (15)

36.84 (14)

Every Couple of Months

41.57 (37)

43.14 (22)

39.47 (15)

Never

-

-

-

Not Reported

5.62 (5)

3.92 (2)

7.89 (3)

2-3 Times per Month

6.74 (6)

9.80 (5)

2.63 (1)

Once a Month

17.98 (16)

13.73 (7)

23.68 (9)

Every Couple of Months

68.54 (61)

70.59 (36)

65.79 (25)

Not Reported

6.74 (6)

5.88 (3)

7.89 (3)

15-30 Minutes

4.49 (4)

3.92 (2)

5.26 (2)

30-45 Minutes

46.07 (41)

43.14 (22)

50.00 (19)

45 Minutes-1 Hour

29.21 (26)

27.45 (14)

31.58 (12)

More than 1 Hour

17.98 (16)

23.53 (12)

10.53 (4)

Not Reported

2.25 (2)

1.96 (1)

2.63 (1)

Length of First Visit

Frequency of Follow-Up Visits
First Month

Months 2-3

Months 4-6

Months 7-12

Length of Follow-Up Visits

1

Column percentages are shown.
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3. Non-Visit Administrative Time
All providers and office/administrative staff were asked to estimate the amount of time that
they personally spent outside of the face-to-face visit doing, for example, case management and
preparing for face-to-face visits, per month. These questions were asked once, not separately for the
three categories of metabolic disorders identified on NBS described above. The time spent on
administrative tasks has been separated based on provider type to reflect the responsibilities of clinical
geneticists and other providers. A total of 93 respondents answered at least one question about the
amount of time they spent on non-visit administrative tasks.
Table 3a shows the amount of time that providers spent on the administrative tasks. Nearly
30% of providers reported spending less than 30 minutes on the phone with the family of a patient with
a metabolic disorder per month. One quarter of providers stated that they spent between thirty
minutes and one hour on the phone with families each month, while an additional 22% reported
spending between one and two hours on the phone each month. Eight percent of all providers reported
that talking to the family on the phone was not one of their administrative responsibilities. Differences
in time spent on the telephone were evident by provider type. Clinical geneticists were more likely than
other providers to report spending less than 30 minutes on the phone with families while other
providers were more likely than clinical geneticists to report spending between two and four hours per
month on the phone with families.
Providers reported spending a substantial amount of time on case management each month.
Providers most frequently reported spending between thirty minutes and one hour on this task (31%),
while only 11% reported spending less than 30 minutes on case management per month. Clinical
geneticists most frequently reported spending between thirty minutes and one hour on case
management per month, compared to 20% of other providers. Other providers most frequently
reported spending more than four hours on this task per month (27%).
Providers most frequently reported spending between thirty minutes and one hour preparing
for face-to-face visits each month. Differences in the amount of time spent on this task were evident
between clinical geneticists and other providers. Forty-two percent of clinical geneticists reported
spending this much time on face-to-face visits. Other providers most frequently reported spending
between one and two hours preparing for face-to-face visits (27%).
Providers were also asked how many hours they spent on other, non-specified administrative
tasks per month. Providers most frequently reported spending less than thirty minutes or more than
four hours on these tasks. Again, differences in the amount of time spent by clinical geneticists and
other providers were evident. Clinical geneticists most frequently reported spending less than thirty
minutes on other administrative tasks each month (33%). Providers were asked to describe these other
administrative tasks. Clinical geneticists descriptions included: documentation and dictation; developing
care plans; writing emergency letters; communicating with clinic staff, primary care physicians, other
health professionals, and non-parent family members; reviewing lab results; coordinating patient care
with insurance companies and regional services; advocating for patients and connecting families with
support groups; and working with the NBS program. Comparatively, other providers most frequently
reported spending more than four hours on these tasks each month (29%). Tasks reported by other
providers included: reviewing lab results and revising diet management plans; documentation; writing
emergency letters and letters of medical necessity; communicating with primary care providers, clinical
geneticists, and other health care professionals; coordinating patient care; educating families and
gathering educational materials; compiling information for newsletters; procuring medical foods and
formulas; and connecting families with area resources, including other families whose child(ren)
has/have the same disorder.
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Table 3a. Non-Visit Administrative Time

1

Provider Type
Total
(n=93)

Clinical Geneticists
(n=52)

Other Providers
(n=41)

Less than 30 minutes

29.03 (27)

34.62 (18)

21.95 (9)

30 minutes-1 hour

24.73 (23)

25.00 (13)

24.39 (10)

1-2 hours

21.51 (20)

23.08 (12)

19.51 (8)

2-4 hours

11.83 (11)

7.69 (4)

17.07 (7)

More than 4 hours

5.38 (5)

3.85 (2)

7.32 (3)

I don't do this

7.53 (7)

5.77 (3)

9.76 (4)

Not Reported

-

-

-

Less than 30 minutes

10.75 (10)

7.69 (4)

14.63 (6)

30 minutes-1 hour

31.18 (29)

40.38 (21)

19.51 (8)

1-2 hours

19.35 (18)

25.00 (13)

12.20 (5)

2-4 hours

17.20 (16)

13.46 (7)

21.95 (9)

More than 4 hours

18.28 (17)

11.54 (6)

26.83 (11)

I don't do this

3.23 (3)

1.92 (1)

4.88 (2)

Not Reported

-

-

-

Less than 30 minutes

15.05 (14)

17.31 (9)

12.20 (5)

30 minutes-1 hour

31.18 (29)

42.31 (22)

17.07 (7)

1-2 hours

22.58 (21)

19.23 (10)

26.83 (11)

2-4 hours

12.90 (12)

9.62 (5)

17.07 (7)

More than 4 hours

12.90 (12)

7.69 (4)

19.51 (8)

I don't do this

1.08 (1)

0.00 (0)

2.44 (1)

Not Reported

4.30 (4)

3.85 (2)

4.88 (2)

Less than 30 minutes

23.66 (22)

32.69 (17)

12.20 (5)

30 minutes-1 hour

17.20 (16)

15.38 (8)

19.51 (8)

1-2 hours

17.20 (16)

15.38 (8)

19.51 (8)

2-4 hours

13.98 (13)

15.38 (8)

12.20 (5)

More than 4 hours

21.51 (20)

15.38 (8)

29.27 (12)

I don't do this

1.08 (1)

1.92 (1)

0.00 (0)

Not Reported

5.38 (5)

3.85 (2)

7.32 (3)

No

27.96 (26)

30.77 (16)

24.39 (10)

Yes

70.97 (66)

67.31 (35)

75.61 (31)

Not Reported

1.08 (1)

1.92 (1)

0.00 (0)

Time Spent on Phone with Family per month

Time Spent Doing Case Management per month

Time Spent Preparing for Face-to-Face Visits per month

Time Spent on Other Administrative Tasks per month

Do You Interact with insurance Companies

1

Column percentages are shown.

18

Providers were also asked whether they interacted with insurance companies. As seen in Table
3a, 71% of providers reported doing so. Other providers more frequently reported interacting with
insurance companies than did clinical geneticists. Table 3b contains information on the amount of time
that providers worked with insurance companies; this analysis includes only those providers who
reported working with insurance companies. Overall, providers most frequently reported spending less
than thirty minutes or between one and two hours interacting with insurance companies. Differences
were evident by provider type. Clinical geneticists most frequently reported spending less than thirty
minutes working with insurance companies (26%), while other providers most frequently reported
spending between one and two hours (29%) working with insurance companies.
Table 3b. Amount of Time Spent Interacting with Insurance Companies per month

1

Provider Type
Total
(n=66)

Clinical Geneticists
(n=35)

Other Providers
(n=31)

Less than 30 minutes

21.21 (14)

25.71 (9)

16.13 (5)

30 minutes -1 hour

18.18 (12)

22.86 (8)

12.90 (4)

1-2 hours

21.21 (14)

14.29 (5)

29.03 (9)

2-4 hours

19.70 (13)

20.00 (7)

19.35 (6)

More than 4 hours

16.67 (11)

14.29 (5)

19.35 (6)

I don't do this

1.52 (1)

0.00 (0)

3.23 (1)

Not Reported

1.52 (1)

2.86 (1)

0.00 (0)

1

Column percentages are shown.

Providers were also asked to rank the three most time-intensive reasons that they interact with
insurance companies. Some providers rated more than one activity in the top three; all of these reports
were taken into account in order to describe the variety of reasons why providers interact with
insurance companies. These reports are shown in Table 3c. The most time-intensive reason providers
reported working with insurance companies was for approvals for medical foods and formulas (64%);
this was also the most time-intensive reason reported by both clinical geneticists and other providers.
Approvals for medications was reported to be the second most time-intensive reason for working with
insurance companies; forty-eight percent of all providers and sixty-two percent of clinical geneticists
reported it was second most important. General reimbursement for services was the most frequently
reported third most time-intensive reason for interacting with insurance companies. Thirty-six percent
of all providers, twenty-seven percent of clinical geneticists, and fifty percent of other providers
reported this as the third most time-intensive reasons they worked with insurance companies.
Table 3c. Most Time-Intensive Reasons for Interacting with Insurance Companies among Providers who
1
Interact with Insurance Companies
First

Second

Third

General Reimbursement for Services

9.72 (7)

6.78 (4)

36.07 (22)

Patient Eligibility for Care

8.33 (6)

16.95 (10)

21.31 (13)

Approvals for Medical Foods/Formulas

63.89 (46)

16.95 (10)

4.92 (3)

Approvals for Medications

16.67 (12)

47.46 (28)

6.56 (4)

Approvals for Durable Medical Equipment

0.00 (0)

8.47 (5)

16.39 (10)

All Providers (n=66)
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Approval for Hospital Services

0.00 (0)

1.69 (1)

8.20 (5)

Other

1.39 (1)

1.69 (1)

6.56 (4)

General Reimbursement for Services

11.90 (5)

5.88 (2)

27.03 (10)

Patient Eligibility for Care

7.14 (3)

11.76 (4)

21.62 (8)

Approvals for Medical Foods/Formulas

69.05 (29)

8.82 (3)

8.11 (3)

Approvals for Medications

11.90 (5)

61.76 (21)

2.70 (1)

Approvals for Durable Medical Equipment

0.00 (0)

5.88 (2)

21.62 (8)

Approval for Hospital Services

0.00 (0)

2.94 (1)

10.81 (4)

Other

0.00 (0)

2.94 (1)

8.11 (3)

General Reimbursement for Services

6.67 (2)

8.00 (2)

50.00 (12)

Patient Eligibility for Care

10.00 (3)

24.00 (6)

20.83 (5)

Approvals for Medical Foods/Formulas

56.67 (17)

28.00 (7)

0.00 (0)

Approvals for Medications

23.33 (7)

28.00 (7)

12.50 (3)

Approvals for Durable Medical Equipment

0.00 (0)

12.00 (3)

8.33 (2)

Approval for Hospital Services

0.00 (0)

0.00 (0)

4.17 (1)

Other

3.33 (1)

0.00 (0)

4.17 (1)

Clinical Geneticists (n=35)

Other Providers (n=31)

1

Column percentages are shown.

Finally, dietitians were asked questions specifically about three-day diet recalls. A total of 17
dietitians completed these questions. As shown in Table 3d, dietitians most frequently reported that
51-60% of their patients and families provide a three-day diet recall (29%). Dietitians most frequently
reported spending between fifteen and thirty minutes (53%) preparing a three-day diet recall. Finally,
dietitians were asked what their protocol is when patients and families do not provide diet recall
records. The majority of dietitians (65%) reported that they complete the diet recall record with the
families.
Table 3d. Three Day Diet Recall Protocol among Dietitians
Total (n=17)
Percent of Patients/Families Providing a 3-day Diet Recall
0-10%

5.88 (1)

11-20%

-

21-30%

11.76 (2)

31-40%

5.88 (1)

41-50%

11.76 (2)

51-60%

29.41 (5)

61-70%

11.76 (2)

71-80%

17.65 (3)

81-90%

5.88 (1)

91-100%

-

Average Time Spent Preparing a 3-day Diet Recall
15-30 minutes

11.76 (2)

20

30-45 minutes

52.94 (9)

45 minutes-1 hour

23.53 (4)

More than 1 hour

5.88 (1)

Not Reported
Procedure When Patients/Families Do Not Provide Diet Recall (select all that apply)
Complete diet recall with them
Ask them to complete a diet recall during the visit and review it with them that day
Ask them to complete a diet recall at home and send it to the office for review and follow-up
Other

5.88 (1)
64.71 (11)
11.76 (2)
11.76 (2)
11.76 (2)

4. Care Coordination and Models of Care Provision
Providers were asked to answer a number of questions regarding their responsibilities with
patients and any models of care provision they used in practice. These questions were asked of all
providers; sample sizes vary throughout this section because of skip patterns.
First, providers were asked to rank their top three responsibilities when working with patients
and their families. Some providers rated more than one activity in the top three; all of these reports
were taken into account in order to describe the variety of responsibilities providers have when working
with patients. These are shown in Table 4a. Managing patients’ medical needs was the primary
responsibility most frequently reported by providers (39%); educating patients and families was the
most frequently reported secondary responsibility reported by providers (33%); communicating with
primary care providers was the most frequently reported tertiary responsibility reported by providers
(23%). Reported responsibilities varied by provider type. Clinical geneticists most frequently reported
that they were responsible for managing medical needs (59%), managing dietary needs (37%), and
educating patients and families (31%). Other providers most frequently reported managing dietary
needs (34%), educating patients and families (42%), and coordinating care for patients and families
(26%).

Table 4a. Primary Responsibilities of Providers when Working with Patients and Their Families

1

First

Second

Third

Coordinate Care for Patient and Family

13.33 (14)

7.37 (7)

17.89 (17)

Interact with Insurance Companies for Patients

0.95 (1)

2.11 (2)

7.37 (7)

Advocate for Patient Services

0.00 (0)

3.16 (3)

6.32 (6)

Manage Dietary Needs

20.00 (21)

24.21 (23)

5.26 (5)

Manage Medical Needs

39.05 (41)

11.58 (11)

3.16 (3)

Educate Patients and Families

16.19 (17)

32.63 (31)

18.95 (18)

Identify/Refer Patients to Community Resources, Support Groups, etc.

0.00 (0)

7.37 (7)

5.26 (5)

Communicate with Primary Care Providers

4.76 (5)

7.37 (7)

23.16 (22)

Communicate with Specialists, Hospital Staff, etc.

2.86 (3)

4.21 (4)

7.37 (7)

Other

2.86 (3)

0.00 (0)

5.26 (5)

13.11 (8)

5.77 (3)

10.20 (5)

All Providers (n=87)

Clinical Geneticists (n=49)
Coordinate Care for Patient and Family
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Interact with Insurance Companies for Patients

0.00 (0)

1.92 (1)

2.04 (1)

Advocate for Patient Services

0.00 (0)

3.85 (2)

6.12 (3)

Manage Dietary Needs

9.84 (6)

36.54 (19)

10.20 (5)

Manage Medical Needs

59.02 (36)

13.46 (7)

2.04 (1)

Educate Patients and Families

14.75 (9)

25.00 (13)

30.61 (15)

Identify/Refer Patients to Community Resources, Support Groups, etc.

0.00 (0)

3.85 (2)

2.04 (1)

Communicate with Primary Care Providers

1.64 (1)

7.69 (4)

26.53 (13)

Communicate with Specialists, Hospital Staff, etc.

1.64 (1)

1.92 (1)

6.12 (3)

Other

0.00 (0)

0.00 (0)

4.08 (2)

Coordinate Care for Patient and Family

13.64 (6)

9.30 (4)

26.09 (12)

Interact with Insurance Companies for Patients

2.27 (1)

2.33 (1)

13.04 (6)

Advocate for Patient Services

0.00 (0)

2.33 (1)

6.52 (3)

Manage Dietary Needs

34.09 (15)

9.30 (4)

0.00 (0)

Manage Medical Needs

11.36 (5)

9.30 (4)

4.35 (2)

Educate Patients and Families

18.18 (8)

41.86 (18)

6.52 (3)

Identify/Refer Patients to Community Resources, Support Groups, etc.

0.00 (0)

11.63 (5)

8.70 (4)

Communicate with Primary Care Providers

9.09 (4)

6.98 (3)

19.57 (9)

Communicate with Specialists, Hospital Staff, etc.

4.55 (2)

6.98 (3)

8.70 (4)

Other

6.82 (3)

0.00 (0)

6.52 (3)

Other Providers (n=38)

1

Column percentages are shown.

Second, providers were asked about provision of care models used in their practices. Providers
were asked to rank from most to least important five models of care provision: using a team approach
to care, practicing at satellite clinics, making visits to patient homes, using telemedicine technologies,
and serving as a medical home. Providers who reported that their practice used a particular model of
care were then asked follow-up questions with regard to that model. A total of eighty-six providers
responded to questions regarding models of care.
Overall, ninety-nine percent of providers reported that their clinic used a team approach to
caring for patients, forty-five percent reported that they practiced at satellite clinics, nineteen percent
reported making home visits, twenty-six percent reported using telemedicine technologies, and sixtyfive percent reported serving as a medical home for patients. The comparative importance of models of
care is shown in Table 4b. Using a team approach to care was rated as most important by ninety
percent of providers. Serving as a medical home and practicing at satellite clinics were most frequently
ranked second and third most important models of care provision. Utilizing telemedicine technologies
was most frequently ranked fourth most important. Additionally, thirty percent of providers reported
that their clinic had a person who worked specifically as a care coordinator (data not shown).
Table 4b. Models of Patient Care Used by All Providers' Practices/Clinics (n=86)

Using a Team Approach to Care
Practicing at Satellite Clinics
Making Visits to Patients' Homes
Using Telemedicine Technologies

Most
Important
89.77 (79)
4.55 (4)
0.00 (0)
0.00 (0)

2nd Most
Important
4.76 (3)
30.16 (19)
4.76 (3)
6.35 (4)

1

3rd Most
Important
2.56 (1)
25.64 (10)
20.51 (8)
23.08 (9)

4th Most
Important
10.53 (2)
15.79 (3)
15.79 (3)
42.11 (8)

Least
Important
0.00 (0)
33.33 (3)
22.22 (2)
11.11 (1)
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Serving as a Medical Home

5.68 (5)

53.97 (34)

28.21 (11)

15.79 (3)

33.33 (3)

1

Column percentages are reported.

All eighty-five providers who reported that their practice utilized a team approach to care were
asked to indicate who else participated in patient care teams, excluding themselves. Provider responses
are contained in Table 4c. More than half of providers reported that teams were composed of clinical
geneticists, dietitians/nutritionists, social workers, nurse, and genetic counselors. Patient advocates,
office/administrative managers, primary care providers, metabolic laboratory directors, and other
providers were included less frequently. ‘Other’ providers were specified by respondents and included
nurse practitioners (n=6), medical assistants (n=1), psychologists (n=1), physician assistants (n=1), and
biochemical genetics fellows (n=1).
Table 4c. Team Membership (Excluding
Respondent) Among Those Who Reported
Working On a Team
Total
(n=85)
Clinical Geneticist
54.12 (46)
Dietitian/Nutritionist
84.71 (72)
Social Worker
51.76 (44)
Nurse
64.71 (55)
Patient Advocate
3.53 (3)
Office/Administrative Manager
47.06 (40)
Primary Care Providers
43.53 (37)
Genetic Counselor
63.53 (54)
(Metabolic) Laboratory Director
40.00 (34)
Other
10.59 (9)

Given the importance that providers gave them in the survey, it is unsurprising that a number of
comments in the Best Practices and Wrap-Up sections of the survey discussed the team approach. Six
providers mentioned the importance of the multidisciplinary team approach; three simply stated:
“The multidisciplinary approach to care helps meet the complex needs of patients and families
and divides the workload.”
“Our team approach is very valuable to us.”
“When the parents of children have easy access to the coordinator, dietician, social worker,
clinic staff, and the physician, everything works much better. This is especially important for
children on special diets…”
In fact, three others noted other team members (a social worker, dietitian, and administration/billing
person) and two others discussed the need to expand the team. One stated that the clinic has had
difficulty utilizing the team approach because of the “lack of care providers interested in caring for
[inborn errors of metabolism].” Two providers pointed to the importance of other team members for
easing clinical geneticists’ workload and as a way of addressing the shortage of clinical geneticists:
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“A knowledgeable and dedicated metabolic dietician and nurse practitioner have greatly eased
the load from our metabolic physicians.”
“Metabolic/Genetic Nurse Practitioner/Dietitian partnerships work well for chronic
management of most [inborn errors of metabolism] and should be cultivated given the increase
[in] patient load and fewer biochemically trained physicians.”
Of the thirty-nine providers who reported that their practice utilized satellite clinics, only
twenty-seven providers responded to follow-up questions regarding these clinics. The reports of these
twenty-seven providers are contained in Table 4d. Providers reported working at a variety of satellite
clinics; thirty-seven reported working at two clinics, while 30% reported working at three or more clinics.
However, most providers (74%) reported only working at satellite clinics one to two days per month.
Providers were also asked to identify the top three reasons they practice at satellite clinics. Nearly all
(96%) reported that satellite clinics were geographically easier for patients, while twenty-six percent
reported that they practiced at satellite clinics because of uninsured patients.
Table 4d. Characteristics of Satellite Clinic Practice Among Those Providing
Care at these Places
Total (n=27)
Number of Satellite Clinics Practiced At
One
33.33 (9)
Two
37.04 (10)
Three or More
29.63 (8)
Number of Days Practicing at Satellite Clinics per Month
1-2 days
74.07 (20)
3-5 days
7.41 (2)
6-10 days
11.11 (3)
11-20 days
More than 20 days
3.70 (1)
Not Reported
3.70 (1)
Top Reasons for Practicing at Satellite Clinics
Geographically Easier for Patients
96.30 (26)
Satellite Clinic Specialization
11.11 (3)
Provider Convenience
7.41 (2)
Contractual Obligations
22.22 (6)
Financial Incentives of State Mandate
18.52 (5)
Uninsured Patients
25.93 (7)
Clinics Affiliate with my Employer (e.g., outreach facility) 22.22 (6)
Personal Beliefs
14.81 (4)
Other Patient Barriers
7.41 (2)
Other
3.70 (1)

Sixteen providers reported making visits to patients’ homes; however, only twelve providers
answered follow-up questions regarding these visits. Their responses are contained in Table 4e. Most
providers (67%) reported making home visits one to two days per month. Providers were also asked the
top three reasons they made home visits. Half of providers reported that they made home visits
because they were geographically easier for patients and because of other patient barriers. Those other
patients barrier included a lack of transportation (n=3), a “need to understand the environment” (n=1),
and to “see why [families] can’t be compliant” (n=1).
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Table 4e. Characteristics of Home Visit Practices Among Those Making Home
Visits
Total (n=12)
Number of Days Making Home Visits per Month
1-2 days
66.67 (8)
3-5 days
16.67 (2)
Not Reported
16.67 (2)
Top Reasons for Making Home Visits
Geographically Easier for Patients
50.00 (6)
Provider Convenience
Contractual Obligations
Financial Incentives of State Mandate
8.33 (1)
Uninsured Patients
Personal Beliefs
25.00 (3)
Other Patient Barriers
50.00 (6)
Other
16.67 (2)

All twenty-two providers who reported that their practice utilized telemedicine responded to
follow-up questions regarding telemedicine. Their responses are contained in Tables 4f and 4g. As
shown in Table 4f, eighty-two percent of providers utilize remote patient monitoring and fifty-nine
percent report utilizing remote patient visits Providers most frequently reported utilizing these types of
telemedicine one to two days per month (44% and 46% respectively), as shown in Table 4g. Thirty-six
percent of providers reported using some other type of telemedicine. Finally, half of providers who use
telemedicine reported that it could be improved to assist in the care of metabolic patients. Three
providers mentioned difficulty accessing telemedicine and four reported that they needed the
technology and equipment to be both better and simpler. Providers also mentioned that families’
comfort with telemedicine was an issue (n=1) and that telemedicine needed to be better reimbursed
(n=1). Finally, two providers offered ideas of how they would like to use telemedicine technologies but
currently cannot:
"I respond to patient questions. Would be good to be more proactive in reaching them but there
is insufficient time to do so."
"It would be better if we could actually have local providers help us with the physical exam."
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Table 4f. Characteristics of Telemedicine Practice among Those Who Use
Telemedicine
Total (n=22)
Remote Patient Monitoring
No
18.18 (4)
Yes
81.82 (18)
Remote Patient Visits
No
40.91 (9)
Yes
59.09 (13)
Other Types of Telemedicine
No
63.64 (14)
Yes
36.36 (8)
Reasons for Using Telemedicine
Geographically Easier for Patients
81.82 (18)
Provider Convenience
54.55 (12)
Contractual Obligations
4.55 (1)
Financial Incentives of State Mandate
Uninsured Patients
Provider-to-Provider Communication about Patient
22.73 (5)
Personal Beliefs
9.09 (2)
Other Patient Barriers
9.09 (2)
Other
4.55 (1)
Could Telemedicine Be Improved
No
31.82 (7)
Yes
50.00 (11)
Not Reported
18.18 (4)
Table 4g. Number of Days Per Month Providers Use
Telemedicine

1-2 days
3-5 days
6-10 days
11-20 days
More than 20
days
Not Reported

Remote Patient
Monitoring
(n=18)
44.44 (8)
27.78 (5)
11.11 (2)
5.56 (1)

Remote
Patient Visits
(n=13)
46.15 (6)
23.08 (3)
7.69 (1)
7.69 (1)

5.56 (1)
5.56 (1)

15.38 (2)

Of the fifty-six providers who reported that their practice serves as a medical home, fifty-five
providers responded to follow-up questions. Sixty percent of providers stated that their practice served
as the medical home for patients with metabolic conditions diagnosed following a positive newborn
screening. Of the twenty-two providers who stated that their practice did not serve as a medical home
or were not sure if their practice served as a medical home, fifty-nine percent stated that one of the
patients’ other providers served as the medical home. Of those thirteen providers, twelve responded
that the patients’ primary care providers served as the medical home; one provider declined to answer.
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5. Challenges to Providing Care
Providers were asked to respond to a series of statements regarding challenges they face
providing care to patients with metabolic conditions diagnosed following a positive NBS during the first
year of life. Statements reflected a variety of potential challenges, including geographic distance, clinic
staffing, and educational needs and responsibilities. Response categories ranged from ‘very challenging’
to ‘not at all challenging.’ A total of 84 providers responded to at least one statement; their responses
are contained in Figure 5 (Appendix C, Table 5). These analyses were not bifurcated by provider type.
Providers reported that factors associated with families were challenging. More than half of
respondents reported that parental/familial knowledge and awareness of the metabolic disorder (64%)
and compliance with treatment and management protocols (55%), and language barriers (52%) between
providers and patients/families were somewhat challenging. Fifty-one percent of providers stated that
the geographic distance between providers and families was somewhat challenging; an additional 43%
stated that distance was very challenging. Three comments were made reflecting this challenge:
“Our clinic services the entire state so we face challenges in actually getting families to clinic.
Some of our patients drive from 3 or more hours away to be seen and when a condition calls for
that perhaps more than every couple of months.”
“The size of the catchment area and ability to get the services to families far away.”
“Solo practice with too large a geographic area to know all the community resources as well as
needed for optimal care.”
Factors associated with the health care system were also considered challenging. Fifty-two
percent of providers reported that having to take on multiple roles when providing care was somewhat
challenging; an additional thirteen percent of providers reported it was very challenging. Primary care
providers knowledge of metabolic disorders was also reported as challenging – twenty-five percent of
providers reported it was very challenging and forty-eight percent of providers reported it was
somewhat challenging. One provider commented that, “our attempts to educate [primary care
providers] have also met with resistance.” Additionally, providers frequently reported that having
enough time to provide patients/families with all necessary resources was very (41%) or somewhat
(44%) challenging. Forty-six percent of providers rated the ability to transition patients to hospital
providers when necessary as not very challenging.
Providers reported that the most challenging aspect of their work was the lack of
reimbursement for all of the care that patients and families need. Sixty-two percent of providers
reported that reimbursement was very challenging. An additional 27% rated reimbursement as
somewhat challenging. That providers’ find reimbursement challenging was reflected in their comments
at the end of the survey; ten providers specifically mentioned reimbursement. One provider summed
the problem with reimbursement succinctly: “Very poor reimbursements for the clinic visits. No
reimbursement for all the time spent on patient care outside of clinic. We lose money on every patient
we see. We are dependent on philanthropy and the small amount the State provides to survive.”
Two other providers actually reported that reimbursement was not an issue because they were state
employees; one stated, “I am fortunate to work in a state with a coordinated program -- we work closely
with the NBS program and have funding to support [a registered dietitian, social worker], and other staff
to provide comprehensive care.”
Fifty-four percent of providers reported the adequacy of clinic staffing was very or somewhat
challenging. Nine providers specifically mentioned staff adequacy as an issue they faced; three
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mentioned general staffing issues, while three mentioned the specific lack of a physician, a social work,
and a staff member in charge of billing/referral, respectively. Three providers mentioned the need for
clinical geneticists trained in metabolic conditions:
“The greatest challenge is the number of patients and the relative lack of enough qualified
physicians who are able to provide knowledgeable care. We need more geneticists trained in
metabolic diseases.”
“Clinical Geneticists [are] untrained in metabolism or nutrition.”
“Knowledgeable faculty to diagnose and treat rare disorders. Maybe the federal government
needs to offer funding for metabolic specialists. How about mandating a metabolic specialist for
every state?”
Unique insurance protocols and the availability of prescription medications and medical foods
were related challenges. Seventy-seven percent of providers reported that insurance protocols were
somewhat or very challenging. Eight providers mentioned general insurance issues in their comments.
Providers stated:
“Largest amount of time is spent chasing insurance issues around and that is the one area where
we have no support so providers and limited office staff end up spending their time doing it.”
“Insurance issues are overwhelming at times.”
“We are all feeling overworked and underappreciated. We seem to always have to battle for
our patients and their care needs as we deal in rare disorders and insurers, etc. have not heard
of most of them.”
Eighty-seven percent of providers reported that the availability of prescription medications
and/or medical foods was somewhat or very challenging. Fourteen providers commented that working
with insurers for medical foods and formulas was difficult:
“The paperwork alone required for the medications/formulas/foods is quite time consuming.”
“Making insurers aware of the needs of metabolic [patients] specifically the need to cover
medications and medical foods.”
“Fighting with insurance companies to cover for medical nutrition products.”
“Too much insurance resistance to cover formula, meds, food, testing, etc.”
“Refusal of coverage by health plan providers for medical foods, modified low protein foods,
medications used to treat IEM.”
“Getting the appropriate medical beverage/ foods covered to ensure appropriate standard of
care.”
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Not only is dealing with insurance companies to cover medical foods and formulas time consuming, but
patients’ quality of care and health is at stake if providers are unable to demonstrate the importance of
such treatments to insurance companies.
The interconnectedness of the issues discussed above – the time spent with patients,
compliance, staffing adequacy, and reimbursement – are reflected in two provider comments. These
providers stated:
“The greatest challenge is donating the necessary time to the patients. Ongoing communication
and a strong bond between doctor and patient/parent is the key to successful treatment, and
metabolic geneticists are in short supply but high demand.”
“Since care for these disorders is not well reimbursed, we are not well staffed. Staffing and time
are constant problems.”
Thirty-eight percent rated their own educational needs regarding metabolic disorders as not
very challenging, despite the fact that thirty-four percent of providers reported needing periodic and
twenty-seven percent reported appreciating frequent updates about metabolic disorders and care
practices. One reason why providers own educational needs may not be a substantially challenging
issue can be traced to the comments providers included in the survey. Four separate providers stated
that they have found sharing ideas with other providers and clinics was valuable. Three of these
providers specifically cited electronic methods of communication; two stated:
“ListServes among metabolic providers has been VERY helpful for sharing information and case
reports.”
“ListServes have been very VALUABLE as a way to communicate with other metabolic
providers.”
Forty-two percent of providers reported that their communication with state NBS or follow-up
programs was not at all challenging. One provider stated that “a close partnership between the
newborn screening program and the metabolic clinicians helps facilitate rapid interpretation of results
and proper emergent management when necessary.” One of the four providers who was experiencing
difficulty working with NBS systems reported that “the lack of communication from the state NBS lab to
our in-house NBS coordinator to the MD/RD involved in the care of metabolic patients has greatly
increased over the last year [has resulted in a] delay in working with positive cases.”
One other challenge was mentioned in provider comments that was not included in the survey.
Four providers mentioned the lack of knowledge of the history of the disorder and lack of guidelines for
care. Two providers stated:
“A consensus on one way to treat the particular disorder. Every center treats patients
differently.”
“Lack of knowledge about the prognosis and best treatments as well as the natural history of
many of the disorders and the fact that there is not a systematic way to address this problem.”
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Figure 5. Challenges to Providing Care During the First Year of Life
(n=84)
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6. Education
Providers were asked to share information on the educational practices and resources they use
when working with families. A total of 86 providers answered at least one question in the education
section of the survey. These analyses were not examined by provider type.
First, providers were asked to indicate the three things about which they educate families. Two
topics were reported by nearly all providers: treatment and management for the disorders (95%) and
basic information about the disorder (90%). Approximately half of providers also reported educating
families about the complications (50%) and prognosis (48%) of the disorder.
Next providers were asked about the average amount of time per month that they spend
educating families of children with metabolic disorders from birth to age one. Providers most frequently
reported spending between one and two hours each month (31%) educating families. Approximately
38% of providers reported spending between three and ten hours educating families each month.
Seven percent of providers reported spending more than twenty hours each month educating families.
Providers were also asked to indicate the three educational materials they use most frequently
with families. The majority of providers reported using pamphlets and resource binders (87%), websites
(86%), and support groups (67%) to educate families. Fewer providers reported educating families with
parent advocates (13%) and other materials (12%).
In their comments, two providers reported needing additional educational materials. One
reported the need for easy to read educational materials for families; another discussed the need for
educational materials explaining the difference between true and false positives, and borderline results.
Three providers indicated that they needed more time to educate families on metabolic disorders; these
providers stated:
“…time to educate our lower literacy families on the disorders.”
“Because we have a regional program and a very small team, we don't see the children often
and I think this impairs our ability to teach the families important aspects of the disorders.”
“Having the time to educate the families and primary care providers about the metabolic
disorder and their role in management. “
Providers also reported that the most common resources of information that families used were
websites (100%) and pamphlets (58%). Previous experience with metabolic disorders (35%) and contact
with follow-up coordinators (29%) and primary care providers (22%) were also frequently cited sources
of education used by families. Given the sources of education used by families, providers reported that
the information families have about metabolic disorders when they visit the providers’ practice is only
accurate sometimes (69%).
Table 6. Educational Practices and Resources Used by Providers
Total
(n=86)
Things Providers Educate Families About
Basic Information About the Disorder

89.53 (77)

Treatment/Management for the Disorder

95.35 (82)

Complications of the Disorder

50.00 (43)
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Prognosis of the Disorder

47.67 (41)

Other Services that the Patient May Need

16.28 (14)

Insurance Protocols Pertaining to the Disorder

6.98 (6)

Other

2.33 (2)

Number of Hours Spent Educating Families per month
Less than 1 hour

10.47 (9)

1-2 hours

31.40 (27)

3-5 hours

19.77 (17)

6-10 hours

18.60 (16)

11-20 hours

12.79 (11)

More than 20 hours

6.98 (6)

Educational Materials Providers Use Most Frequently (select three)
Pamphlets/Resource Binders

87.21 (75)

Parent Advocates

12.79 (11)

Support Groups

67.44 (58)

Websites

86.05 (74)

Other

11.63 (10)

Most common Sources of Information Used by Families (select three)
Websites

100.00 (86)

Previous Experience with Disorder

34.88 (30)

Pamphlets

58.14 (50)

NBS Follow-up Coordinator

29.07 (25)

Primary Care Providers

22.09 (19)

Other

12.79 (11)

How Often Information Families have about Disorders are Accurate
Always

0.00 (0)

Often

9.30 (8)

Sometimes

68.60 (59)

Rarely

18.60 (16)

Never

0.00 (0)

Not Applicable

2.33 (2)

Not Reported

1.16 (1)

7. Relationships with Primary Care Providers
Providers were asked about the relationships between primary care providers and metabolic
professionals. A total of 84 metabolic providers answered questions regarding their relationships with
primary care providers; those results are presented here. Only one primary care provider was eligible
for the final sample of providers used in this analysis; therefore, those results are not presented.
Seventy-six percent of metabolic providers reported working with primary care providers;
nineteen percent reported that they did not work with primary care providers (data not shown). All
metabolic providers – whether or not they worked with primary care providers – were eligible to answer
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questions about their perceptions of primary care providers’ knowledge and communication with
primary care providers.
Metabolic providers were asked to rate their level of agreement from ‘strongly agree’ to
‘strongly disagree’ on four general perceptions about primary care providers. These are shown in Figure
7a (Appendix C, Table 7a). The majority of metabolic providers agreed or strongly agreed that providers
often lack knowledge about metabolic disorders on the NBS panel (94%). Despite this, most providers
also agreed or strongly agreed that primary care providers should participate on metabolic care teams
(73%) and act as the medical home for patients (64%). However, only thirty-two percent of providers
agreed or strongly agreed that primary care providers should act as a liaison to the insurance company
for patients with metabolic disorders.
Metabolic providers were also asked to rate their level of agreement from ‘strongly agree’ to
‘strongly disagree’ on three measures of communication with primary care providers. Eighty-two
percent of metabolic providers agreed or strongly agreed that communicating with primary care
providers was a priority, including forty-eight percent who reported they strongly agreed. Eighty
percent of metabolic providers agreed or strongly agreed that communication with primary care
providers provides easy to use, factual information about the patients’ health. Sixty percent agreed or
strongly agreed that communication occurs both from metabolic providers to primary care providers
and from primary care providers to metabolic providers.
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Figure 7a. Metabolic Perceptions of Primary Care Providers
Participation in Patient Care (n=84)
Strongly Agree

Agree Somewhat

Neither Agree nor Disagree

Strongly Disagree

Don't Know/ Not Applicable

Not Reported

Disagree Somewhat

General Perceptions

PCPs should act as the liaison to the patient's insurance company

PCPs should act as the medical home for metabolic patients in the first year
of life

PCPs often lack knowledge of the metabolic disorders detected on uniform
screening panel

Communication with PCPs

Primary care providers (PCPs) should participate on metabolic patient care
teams

Communication with primary care providers is a priority

Communication provides easy to utilize, factual information about the
child’s conditions, treatment, prognosis, medications, and co-morbid
conditions

Communication occurs in both directions
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Metabolic providers were also asked to rate the effectiveness of methods that facilitate the
sharing of patient management with primary care providers from ‘very effective’ to ‘not effective at all.’
These results are shown in Figure 7b (Appendix C, Table 7b). Metabolic providers most frequently
reported written emergency care plans (77%) and consultation letters from specialists (63%) as very
effective. Condition-specific fact sheets (88%) and shared or interoperable electronic health records
(81%) were rated very to somewhat effective. Metabolic providers rated active care plans (48%),
regular email communication (48%), and periodic conference calls (43%) most frequently as somewhat
effective.
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Figure 7b. Effectiveness of Methods to Share Patient Management
with Primary Care Providers (n=84)
Very Effective

Somewhat Effective

Not Very Effective

Not Effective At All

Don't Know/ Not Applicable

Not Reported

Periodic conference calls, including specialty and primary care providers,
parents, others
Active plan of care or action plan identifying current care needs, who will
provide action, and when the action should be completed

Written emergency care plan

Consultation letter from the specialist describing findings, actions taken,
and plans

Condition-specific “fact sheet” with key information about the condition

Shared or interoperable electronic health records

Regular email communication with primary care providers

Other
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Finally, providers were asked to rank the top three ways they communicated with primary care
providers after a patient’s routine visit. Some providers rated more than one activity in the top three;
all of these reports were taken into account in order to describe the variety of methods providers use to
communicate with primary care providers. These responses are contained in Table 7c. The most
common primary ways of communicating with primary care providers were phone call (41%) and fax
(35%).
Table 7. Most Common Methods of Communications with PCPs
1
(n=84)
First

Second

Third

Email

3.37 (3)

24.32 (18)

32.81 (21)

Fax

34.83 (31)

20.27 (15)

23.44 (15)

Phone Call

40.45 (36)

31.08 (23)

20.31 (13)

Postal Mail

17.98 (16)

21.62 (16)

23.44 (15)

Other

3.37 (3)

2.70 (2)

0.00 (0)

1

Column percentages are shown.

8. Attitudes About Expanding the Newborn Screening Panel
In an effort to learn about providers attitudes about expanding the NBS panel, providers were
asked to rate their level of agreement with a series of statements about the impact of expanding the
panel from ‘strongly agree’ to ‘strongly disagree.’ A total of 83 providers had valid responses to at least
one of these statements and were included in these analyses. Analyses are contained in Figure 8
(Appendix C, Table 8).
Providers most frequently strongly agreed that there are not currently enough providers
educated to care for patients with metabolic disorders on an expanded NBS panel (63%). Additionally,
metabolic providers strongly agreed that expanding the NBS panel would increase their case load (60%)
and the amount of time spent treating patients (54%). Finally, approximately 40% of providers strongly
agreed that they were concerned about being reimbursed for care they would need to provide to new
patients (41%), and that there would not be evidence-based treatment protocols for the new conditions
(41%). Sixty-four percent of providers were also concerned that an expanded NBS panel would result in
more false-positive disorders being detected. Five providers reported specific concerns about
expanding the NBS panel due to a lack of treatment protocols and advanced testing. They stated:
“There ought to be nationalization of standards of NBS as well as the creation of a budget to
support the effort. The model to follow might be the national highway system.”
“Having treatment guidelines, when they are available, is helpful but I understand that there
isn't always enough evidence to develop a definitive protocol.”
“This will all become very ugly and people will have even less trust in the medical establishment.
Adding Comparative Genomic Hybridization will be a disaster. We need more research on what
these variants of unclear significance mean.”
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“A lack of evidence-based treatment strategies. This is also my biggest concern with regards to
expanding the number of disorders on the screening panel. I am not in favor of identifying
disorders for which there is no effective therapy.”
“Lack of knowledge on the significance, natural history and treatment of many of the expanded
disorders, “
Despite these concerns, seventy-five percent of providers were excited about treating children
with metabolic disorders who would otherwise not have received treatment. Providers also did not
report being concerned that an expanded would make working with parents more difficult; forty-seven
percent disagreed or strongly disagreed with the statement and an additional thirty percent reported
that they neither agreed nor disagreed.
One statement garnered reports that were relatively spread. In response to the statement “I
may refer patients diagnosed with metabolic disorders added to the NBS panel to specialists in those
disorders”, thirty percent of providers agreed or strongly agreed, thirty-five percent disagreed or
strongly disagreed and twenty-one percent neither agreed nor disagreed.
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Figure 8. Attitudes Toward Expanding the NBS Panel (n=83)
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I am concerned about being reimbursed for all of the care that I would
provide to patients diagnosed with a disorder on an expanded NBS panel
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Next Steps and limitations:
This survey was conducted on a broad spectrum of providers who treat patients with metabolic
disorders, but it is not generalizable to all metabolic providers due to selective response. Nonetheless,
the responses here mirror strongly those found in the first phase interview pilot project.
Two themes emerge here. One is that the extra-care process post NBS, specifically care coordination
and education, needs to be investigated for effectiveness and best practices. Care management and
payment management need to be the core functions of at least one team member. The field also needs
to find more consistent and effective ways of educating families and primary care providers.
Secondly is that workforce issues need to be addressed. The current consensus is that resources are
inadequate to handle the intensity of care volume as it currently exists. Expansions to the metabolic
NBS panel without first addressing the ineffectiveness of the current models of care will only exacerbate
these issues. Explored should be reconfigurations to the care teams, better care protocols, and
standard methods of communication across the spectrum of care. The use of technology and
integration into other best practice methods should be a priority.
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Appendix A. Survey
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A National Assessment of the Newborn Screening Workforce
Informed Consent Information
You have been invited to participate in a research project that will examine the process of care for patients diagnosed with
metabolic conditions that are detected on newborn screen (NBS) from diagnosis to the first birthday. While you will not
receive any direct benefits from your participation, the information gathered here will be valuable for informing the current
and ongoing policy discussions regarding reimbursement for genetic services.
This project is being conducted by Robert J. McGrath, Associate Professor in the Department of Health Management and
Policy at the University of New Hampshire (UNH). This project is funded by the National Coordinating Center for the Regional
Genetic and Newborn Screening Service Collaboratives (NCC). This survey asks you questions regarding the process of care
and challenges to providing care for average patients with metabolic conditions. You will not be asked to describe any specific
cases. You will also be asked about how you believe an expanded NBS panel will impact your work.
Your participation is voluntary, and you may withdraw your consent and discontinue participation at any time. Although we
hope that you will answer every question, you are certainly free to skip any questions. Your responses will be kept
confidential. The survey data will only be analyzed and reported in aggregated ways that will not reveal your identity. Thus, no
individual identity will be determinable through demographic variables such as zip code. The results may be used in reports,
publications, and/or presentations.
This project will be successful only if you help us. We know that you are extremely busy, but please take 20 minutes to
complete the confidential survey. Because of the highly specialized field of caregivers we are interviewing, you are one of
approximately 200 health care providers who will be asked to participate in this research. Participation in this study is
expected to present minimal risk to you.
If at any time you have questions or concerns about any procedure in this project, you may e-mail the investigator
(Robert.McGrath@unh.edu) or speak with the investigator by calling 603-862-5047. You should also understand that you will
be able to request a summary of the findings. If you have questions about your rights as a research subject, you may contact
Julie Simpson in UNH Research Integrity Services, by phone 603-862-2003 or email julie.simpson@unh.edu.

Instructions
Thank you for participating in this survey of genetic service providers who treat children with metabolic disorders. This survey
is being conducted by Robert J. McGrath, Associate Professor of Health Management and Policy at the University of New
Hampshire, and is funded by the National Coordinating Center for the Regional Genetic and Newborn Screening Service
Collaboratives.
This survey seeks to understand the scope and intensity of services provided to patients with metabolic disorders and their
families by all caregivers from the time of positive newborn screen (NBS) and subsequent diagnosis of a metabolic disorder,
through the first year of life.
We take a broad view of both the care provided, including time spent with the patient and time spent working on the
patient’s behalf, and the responsibilities of people providing care, including the work of clinical providers and office staff. We
are also interested in your views on the potential consequences of adding tests to your state’s current NBS panel. Your input is
highly valuable in informing current policy discussions nationally.

Thank you for your time and participation.
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1. What is your primary professional role?






Clinical Geneticist
 Patient Advocate [SKIP TO Section 2, Page 8, question 36]
Dietitian/Nutritionist
 Office/Administrative Manager [SKIP TO Part II, Page 6, question 25]
Social Worker
 Genetic Counselor
Nurse
 Primary Care Provider
Other (specify) ___________________________________________________________

2. Approximately what percentage of your practice/work is dedicated to treating children who have been
identified through NBS and subsequently confirmed to have a metabolic disorder?






0-10%
11-20%
21-30%
31-40%
41-50%







51-60%
61-70%
71-80%
81-90%
91-100%

Section 1: Process of Care
In order to assess the scope and intensity of services that you provide to patients with metabolic disorders, we
distinguish among 3 categories of metabolic disorders: organic acid disorders, fatty acid oxidation disorders,
and amino acid disorders. We recognize that there is substantial variation within each category of disorder;
however, please answer the following questions with regards to an average patient in your practice diagnosed
with each type of reference metabolic disorder after a positive NBS from birth through the first year of life.
Also, for all questions, please describe only YOUR workload and not the workload of other professionals with
whom you may work.
While we recognize that not every state tests for all of the disorders on the Uniform NBS panel, we ask only
about the disorders on the panel in order to gain a broad understanding of processes of care across the United
States.

Part I. Processes of Care by Metabolic Disorder Type
3. Do you treat children diagnosed with the following categories of metabolic disorders?
Please check all that apply.
[IF CHECKED - ANSWER PART 1A, pg. 3]
 Organic Acid Disorders (for example, Propionic Academia)
Fatty Acid Oxidation Disorders (for example, Carnitine Uptake Defect /

 Carnitine Transport Defect)
 Amino Acid Disorders (for example, Classic Phenylketonuria)
 I do not treat children diagnosed with any of these types of disorders.

[IF CHECKED - ANSWER PART 1B, pg. 4]
[IF CHECKED - ANSWER PART 1C, pg. 5]
[IF CHECKED - SKIP TO PART II, pg. 6]
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Part IA. Processes of Care for Organic Acid Disorders
For the following questions, please think of an average patient in your practice who has been diagnosed with a disorder of
organic academia from the time of positive screen through the first year of life.

4. Please indicate up to 3 disorders of organic academia that you see most often in your practice.
 Propionic Academia (PROP)
 Methylmalonic Acidemia (Methylmalonyl-CoA Mutase) (MUT)
 Methylmalonic Acidemia (Cobalamin Disorders) (Cbl, A, B)
 Isovaleric Acidemia (IVA)
 3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC)
 3-Hydroxy-3-Methyglutaric Aciduria (HMG)
 Holocarboxylase Synthase Deficiency (MCD)
 B-Ketothiolase Deficiency (BKT)
 Glutaric Acidemia Type I (GA1)
 Not Applicable
5. How soon after the NBS lab detects an abnormal blood result do you typically talk to a patient’s family on
the phone for the first time?
 The Same or Next Day
 Within the Month
 Within the Week
 Within Six Months
 Within Two Weeks
 Later than Six Months
6. Approximately how long is your first phone call with the patient’s family?
 Less than 1 Hour
 4-6 Hours
 1-2 Hours
 More than 6 Hours
 2-4 Hours
7. How soon after the NBS lab detects an abnormal blood result do you typically see a patient and their
family for the first time?
 The Same or Next Day
 Within the Month
 Within the Week
 Within Six Months
 Within Two Weeks
 Later than Six Months
8. Approximately how long is your first visit with a patient and their family?
 Less than 1 Hour
 4-6 Hours
 1-2 Hours
 More than 6 Hours
 2-4 Hours
9. How frequently do you see a patient and their family for follow-up after the first visit during the…
More than Once a Once a Week
Week

First Month
Months 2-3
Months 4-6
Months 7-12











2-3 Times
per Month

Once a
Month

Every Couple
of Months

Never





















10. On average, how long are follow-up visits with you during the first year of life?
 Less than 15 Minutes  45 Minutes-1 Hour
 15-30 Minutes
 More than 1 Hour
 30-45 Minutes
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Part IB. Processes of Care for Fatty Acid Oxidation Disorders
For the following questions, please think of an average patient in your practice who has been diagnosed with a disorder of
fatty acid oxidation from the time of positive screen through the first year of life.

11. Please indicate up to 3 disorders of fatty acid oxidation that you see most often in your practice.
 Carnitine Uptake Defect/Carnitine Transport Defect (CUD)
 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)
 Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)
 Long-Chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)
 Trifunctional Protein Deficiency (TFP)
12. How soon after the NBS lab detects an abnormal blood result do you typically talk to a patient’s family
on the phone for the first time?
 The Same or Next Day
 Within the Month
 Within the Week
 Within Six Months
 Within Two Weeks
 Later than Six Months
13. Approximately how long is your first phone call with the patient’s family?
 Less than 1 Hour
 4-6 Hours
 1-2 Hours
 More than 6 Hours
 2-4 Hours
14. How soon after the NBS lab detects an abnormal blood result do you typically see a patient and their
family for the first time?
 The Same or Next Day
 Within the Month
 Within the Week
 Within Six Months
 Within Two Weeks
 Later than Six Months
15. Approximately how long is your first visit with a patient and their family?
 Less than 1 Hour
 4-6 Hours
 1-2 Hours
 More than 6 Hours
 2-4 Hours
16. How frequently do you see a patient and their family for follow-up after the first visit during the…

First Month
Months 2-3
Months 4-6
Months 7-12

More than
Once a
Week

Once a
Week

2-3 Time
per Month

Once a
Month

Every
Couple of
Months

Never































17. On average, how long are follow-up visits with you during the first year of life?
 Less than 15 Minutes  45 Minutes-1 Hour
 15-30 Minutes
 More than 1 Hour
 30-45 Minutes
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Part IC. Processes of Care for Amino Acid Disorders
For the following questions, please think of an average patient in your practice who has been diagnosed with a disorder of
amino acid metabolism from the time of positive screen through the first year of life.

18. Please indicate up to 3 disorders of amino acid metabolism that you see most often in your practice.
 Argininosuccinic Aciduria (ASA)
 Citrullinemia, Type I (CIT)
 Maple Syrup Urine Disease (MSUD)
 Homocystinuria (HCY)
 Classic Phenylketonuria (PKU)
 Tyrosinemia, Type I (TYR I)
19. How soon after the NBS lab detects an abnormal blood result do you typically talk to a patient’s family
on the phone for the first time?
 The Same or Next Day
 Within the Month
 Within the Week
 Within Six Months
 Within Two Weeks
 Later than Six Months
20. Approximately how long is your first phone call with the patient’s family?
 Less than 1 Hour
 4-6 Hours
 1-2 Hours
 More than 6 Hours
 2-4 Hours
21. How soon after the NBS lab detects an abnormal blood result do you typically see a patient and their
family for the first time?
 The Same or Next Day
 Within the Month
 Within the Week
 Within Six Months
 Within Two Weeks
 Later than Six Months
22. Approximately how long is your first visit with a patient and their family?
 Less than 1 Hour
 4-6 Hours
 1-2 Hours
 More than 6 Hours
 2-4 Hours
23. How frequently do you see a patient and their family for follow-up after the first visit during the…

First Month
Months 1-3
Months 3-6
Months 6-12

More than
Once a
Week

Once a
Week

2-3 Time
per Month

Once a
Month

Every
Couple of
Months

Never































24. On average, how long are follow-up visits with you during the first year of life?
 Less than 15 Minutes  45 Minutes-1 Hour
 15-30 Minutes
 More than 1 Hour
 30-45 Minutes
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Part II. Non-Visit Administrative Time
For each of the following tasks, please estimate the amount of time you personally spend performing each of these non-visit
activities per month during an average patient’s first year of life. These questions do NOT distinguish between disorders of
organic acid, fatty acid oxidation, or amino acid.
Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from the time of
positive screen through the first year of life...

- Dieticians ONLY – ALL others go to page 7
25. What percentage of your patients and their families, when asked, provide a 3-day diet recall record?
 0-10%
 51-60%
 11-20%
 61-70%
 21-30%
 71-80%
 31-40%
 81-90%
 41-50%
 91-100%
26. On average, how long do you spend preparing a 3-day diet recall?
 Less than 15 Minutes  45 Minutes-1 Hour
 15-30 Minutes
 More than 1 Hour
 30-45 Minutes
27. What do you do when patients and their families do not provide diet recall records? Please select all
that apply.





Complete Diet Recall with Them
Ask Them to Complete a Diet Recall during the Visit and Review it with Them That Day
Ask them to Complete a Diet Recall At Home and Send it to the Office for Review and Follow-up
Other (Specify) ___________________________________________________________
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- ALL Providers and Administrative/Office Staff 28. About how long do you spend talking on the phone with the family per month?
 Less than 30 Minutes  2-4 Hours
 30 Minutes-1 hour
 More than 4 Hours
 1-2 Hours
 I don’t do this
29. About how long do you spend doing case management per month?
 Less than 30 Minutes  2-4 Hours
 30 Minutes-1 hour
 More than 4 Hours
 1-2 Hours
 I don’t do this
30. Do you spend time interacting with insurance companies about patients with metabolic disorders?
 No [SKIP TO question 33]
 Yes
31. About how long do you spend interacting with insurance companies per month?
 Less than 30 Minutes  2-4 Hours
 30 Minutes-1 hour
 More than 4 Hours
 1-2 Hours
 I don’t do this
32. Please rank the 3 most time-intensive reasons you interact with insurance companies?
General Reimbursements for Services
Patient Eligibility for Care
Approvals for Medical Foods/Formulas
Approvals for Medications
Approvals for Durable Medical Equipment
Approval for Hospital Services
Other ______________________

First

Second

Third

























33. About how long do you spend preparing for face-to-face visits per month? Please include time that you
spend meeting with medical staff, learning about the disorder, reviewing medical records, etc. but do not
take into account time that you spend doing administrative tasks or working with insurance companies.
 Less than 30 Minutes  2-4 Hours
 30 Minutes-1 hour
 More than 4 Hours
 1-2 Hours
 I don’t do this
34. About how long do you spend doing other administrative tasks not already considered per month?
 Less than 30 Minutes  2-4 Hours
 30 Minutes-1 hour
 More than 4 Hours
 1-2 Hours
 I don’t do this [SKIP TO SECTION 2, Next Page]
35. Please describe these other activities and the amount of time (per month) that each of these

activities takes.
______________________________________________________________________________________
______________________________________________________________________________________
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Section 2: Care Coordination
Part I. General
Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from
the time of positive screen through the first year of life…
36. What are your primary responsibilities when working with patients and their families? Please

rank your top 3 responsibilities.
Coordinate Care for Patient and Family
Interact with Insurance Companies for Patients
Advocate for Patient Services
Manage Dietary Needs
Manage Medical Needs
Educate Patients and Families
Identify and/or Refer Patients to Community
Resources, Support Groups, etc.
Communicate with Primary Care Providers
Communicate with Specialists, Hospital Staff, etc.
Other _______________________________

First

Second

Third








































37. Is there someone at your clinic who works specifically as a care coordinator?
 No
 Yes
38. Practices/clinics use different models to meet the needs of their patients and their patients’ families.
Please rank the following practice models in the order of their importance to you in caring for patients with
metabolic disorders and their families.
Most
2nd Most 3rd Most 4th Most
Least
I/My
Important Important Important Important Important practice
does not
do this

Using a Team Approach to Care
Practicing at Satellite Clinics
Making Visits to Patients’ Homes
Using Telemedicine Technologies
Serving as a Medical Home





































SKIP TO Part II, pg. 9
SKIP TO Part III, pg. 9
SKIP TO Part IV, pg. 9
SKIP TO Part V, pg. 10
SKIP TO Part VI, pg. 11

For each practice model that you or your practice use,
Please respond to EACH of the corresponding sections on that model.
If you use MORE than ONE Model, please answer question 53 in addition to each section.
If you do not use ANY please skip to Part VII (question 57, page 12).
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Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from
the time of positive screen through the first year of life…

Part II. Team Approach to Care
39. Excluding yourself, who else is part of the care team for patients diagnosed with metabolic disorders?
Please check all that apply






Clinical Geneticist
 Office/Administrative Manager
Dietitian/Nutritionist  Primary Care Provider
Social Worker
 Genetic Counselor
Nurse
 (Metabolic) Laboratory Director
Patient Advocate
 Other (Specify) _________________________________________________

Part III. Satellite Clinics
40. At how many satellite clinics do you treat metabolic patients?
 One
 Two

 Three or More
 Not Applicable

41. On average, how many days per month do you practice in satellite clinics and treat patients with
metabolic disorders?
 1 – 2 days
 11 – 20 days
 3 – 5 days
 More than 20 days
 6 – 10 days
42. Please check the top 3 reasons you practice in satellite clinics.






Geographically easier for patients
Satellite clinic specialization
Provider convenience
Contractual obligations
Financial incentives of state mandate







Uninsured patients
Clinics affiliate with my employer (e.g. outreach facility)
Personal belief
Other patient barriers (specify) __________________________
Other (specify) _______________________________________

Part IV. Home Visits
43. How many days per month do you make home visits?
 1 – 2 days
 11 – 20 days
 3 – 5 days
 More than 20 days
 6 – 10 days
44. Please check the top 3 reasons why you make home visits.





Geographically easier for patients
Provider convenience
Contractual obligations
Financial incentives of state mandate






Uninsured patients
Personal belief
Other patient barriers (specify) ________________________
Other (specify) _____________________________________
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Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from
the time of positive screen through the first year of life…

Part V. Telemedicine
45. Do you use remote patient monitoring, for example, remote diet recall or blood testing (i.e. heel sticks),
to care for patients diagnosed with metabolic disorders?
 No [SKIP TO question 47]
 Yes
46. How many days per month do you use the remote patient monitoring?
 1 – 2 days
 11 – 20 days
 3 – 5 days
 More than 20 days
 6 – 10 days
47. Do you use remote patient visits, for example through internet or phone conferencing, to care for
patients diagnosed with metabolic disorders?
 No [SKIP TO question 49]
 Yes
48. How many days per month do you use the remote patient visits?
 1 – 2 days
 11 – 20 days
 3 – 5 days
 More than 20 days
 6 – 10 days
49. Do you use other types of telemedicine (not remote patient monitoring or remote patient visits) to care
for patients diagnosed with metabolic disorders?
 No [SKIP TO question 51]
 Yes
50. Please describe the other types of telemedicine that you use and how frequently you use each type per
month.
______________________________________________________________________________________
______________________________________________________________________________________
51. Please check the top 3 reasons why you use telemedicine to care for patients with metabolic disorders.






Geographically easier for patients
Provider convenience
Contractual obligations
Financial incentives of state mandate
Uninsured patients






Provider-to-provider communication about patient
Personal belief
Other patient barriers (specify) ________________
Other (specify) _____________________________

52. Could telemedicine be improved to assist you in the care of patients with metabolic disorders?
 No

 Yes (specify) _______________________________________________
________________________________________________
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Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from
the time of positive screen through the first year of life…

- ALL Providers 53. Thinking about the variety of practice models discussed here (satellite clinics, home visits, and
telemedicine) that are used in the care of patients diagnosed with metabolic disorders, do you tend to see
the same patients in only one setting or in a variety of settings?
For example, do you utilize satellite clinic visits and telemedicine for the same patient and their family or is
it more likely that you only see the patient and their family in one setting (for example, a satellite clinic)
during their first year of life?
______________________________________________________________________________________
______________________________________________________________________________________

Part VI. Medical Home
54. Does your practice serve as a medical home to patients with metabolic disorders?
 No
 Yes [SKIP TO Part VII, question 57]
 Don’t Know
55. Does one of the other the patient's providers most often serve as a medical home?
 No (Skip to Part VII, question 57)
 Yes
 Don’t Know (Skip to Part VII, question 57)
56. Which of the patient’s other providers serves as the patient’s medical home?






Clinical Geneticist
Dietitian/Nutritionist
Social Worker
Nurse
Patient Advocate







Office/Administrative Manager
Primary Care Providers
Genetic Counselor
(Metabolic) Laboratory Director
Other (specify) _____________________________
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Part VII. Challenges to Providing Care during the First Year of Life
57. Please rate how challenging you find each of the following issues when providing care to patients
diagnosed with a metabolic disorder after a positive NBS and their families during the first year of life.
Very
Somewhat
Not Very
Not at all Don't Know
/ Not
Challenging Challenging Challenging Challenging
Available

Geographic distance between providers and
patients/families
Parental/familial compliance with treatment
and management protocols
Language barriers between providers and
patients/families
The adequacy of staffing at your clinic
Unique protocols of insurance providers
Availability of prescription medications
and/or medical foods
Ability to transition patients to hospital
providers when they are admitted
Having to take on other roles when providing
care to patients/families
Parent/family level of knowledge and
awareness of their child's disorder
Your own educational needs concerning
metabolic disorders detected on NBS
Having enough time to provide
patients/families with all of the resources
they need
Lack of reimbursement for all of the care that
patients/families need
Communication between the State NBS or
Follow-up Programs and providers
Primary care providers' knowledge of
metabolic disorders
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Section 4: Education
Thinking about an average patient in your practice diagnosed with a metabolic disorder detected on NBS from
the time of positive screen through the first year of life…

Part I. Family
58. Please check the top 3 things that you educate families about.








Basic information about the disorder (e. g. natural history, genetics)
Treatment/management for the disorder
Complications of the disorder
Prognosis of the disorder
Other services that the patient may need (e. g. support groups, community resources)
Insurance protocols pertaining to the disorder
Other (specify) _____________________________

59. On average, how many hours per month do you spend educating families?
 Less than 1 Hour
 6 - 10 Hours
 1 - 2 Hours
 11 – 20 Hours
 3 - 5 Hours
 More than 20 Hours
60. Please select the 3 educational materials you use most frequently to teach families about their child’s
disorder.





Pamphlets/resource binders  Other (Specify) _________________________________________________
Parent advocates
 None of the above
Support groups
 Not Applicable
Websites

61. Please rank the top 3 sources of information that families most frequently use to learn about their
child’s metabolic disorder.








Websites
Previous experience with the Disorder (for example, another family member or friend with the disorder)
Pamphlets
NBS follow-up coordinator
Primary care providers
Other (Specify) _________________________________________________
Not Applicable

62. When you meet with families, how often would you say that the information they have about metabolic
disorders when they come to your practice is accurate?







Always
Often
Sometimes
Rarely
Never
Not Applicable
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Part II. Relationships with Primary Care Providers
Please answer the following questions about your relationships with primary care providers with regard to the
treatment of patients diagnosed with metabolic disorders after a positive NBS and their families during the
first year of life.

Answer ONLY if NOT a Primary Care Provider
63. Do you personally work with primary care providers?
 No
 Yes
64. What is your level of agreement with the following statements:
Strongly
Agree

Primary care providers (PCPs) should
participate on metabolic patient care
teams
PCPs often lack knowledge of the
metabolic disorders detected on
uniform screening panel
PCPs should act as the medical home
for metabolic patients in the first year
of life
PCPs should act as the liaison to the
patient's insurance company

Agree
Neither
Disagree Strongly
Somewhat Agree nor Somewhat Disagree
Disagree

Don't Know /
Not Applicable

















































65. Please rate how effective you believe each of the following methods would be to facilitate the sharing of
patient management with a primary care provider…

Periodic conference calls, including specialty
and primary care providers, parents, others
Active plan of care or action plan identifying
current care needs, who will provide action,
and when the action should be completed
Written emergency care plan
Consultation letter from the specialist
describing findings, actions taken, and plans
Condition-specific “fact sheet” with key
information about the condition
Shared or interoperable electronic health
records
Regular email communication with primary
care providers
Other (Specify)_______________________

Very
Effective

Somewhat
Effective

Not Very
Effective

Not
Effective
At All

Don't Know /
Not Applicable
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Please answer the following questions about your relationships with primary care providers with regard to the
treatment of patients diagnosed with metabolic disorders after a positive NBS and their families during the
first year of life.
66. What is your level of agreement with the following statement about your communication with primary
care providers:
Strongly
Agree

Communication occurs in both
directions
Communication provides easy to
utilize, factual information about the
child’s conditions, treatment,
prognosis, medications, and co-morbid
conditions
Communication with primary care
providers is a priority

Agree
Neither
Disagree Strongly Don't Know /
Somewhat Agree nor Somewhat Disagree Not Applicable
Disagree





































67. Please rank the top 3 ways you communicate with primary care providers after a patient has a routine
visit?
Email
Fax
Phone Call
Postal Mail
Other ____________________

1st

2nd

3rd



















Answer ONLY if a Primary Care Provider
68. What is your level of agreement with the following statement about your communication with specialty
care providers:
Strongly
Agree
Neither
Disagree Strongly Don't Know /
Agree Somewhat Agree nor Somewhat Disagree Not Applicable
Disagree

Communication occurs in both
directions
Communication does not explicitly
define my role and responsibilities
Communication provides easy to
utilize, factual information about the
child’s conditions, treatment,
prognosis, medications, and co-morbid
conditions
Communication provides useful
information about the emergency care
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Section 5: Attitudes about Expanding the NBS Panel
69. Please indicate your level of agreement with the following statements regarding NBS.
Strongly
Agree

Increasing the number of metabolic
disorders on the NBS panel in my state
would increase my caseload
Expanding the number of metabolic
conditions on the NBS panel would
increase the time I spend treating
patients.
I may refer patients diagnosed with
metabolic disorders added to the NBS
panel to specialists in those disorders.
I am concerned about being reimbursed
for all of the care that I would provide
to patients diagnosed with a disorder
on an expanded NBS panel
There are not currently enough
practitioners educated to care for
patients diagnosed with metabolic
disorders on an expanded NBS panel
I am concerned that there would not be
evidence-based treatment protocols to
care for children diagnosed with
disorders added to the NBS panel
Adding disorders to the NBS panel will
make working with parents much more
difficult
I am excited to think about being able
to treat children with metabolic
diseases that would otherwise have not
been detected at birth
I am concerned that adding disorders to
the NBS panel would result in a greater
number of false-positives

Somewhat Neither Somewhat Strongly Don't Know /
Agree nor Disagree Disagree Not Applicable
Agree
Disagree
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Section 6: Best Practices
70. This survey has asked you about processes of care and challenges to those processes for patients
diagnosed with a metabolic disorder after a positive NBS and their families from the time of the screening
through the first year of life. Thinking about your experiences and practice, are there any models of care or
other things that have improved the care that patients and their families receive that you would like to
share with us?
__________________________________________________________________________________________
__________________________________________________________________________________________
_________________________________________________________________________________
71. In this survey, we asked about the educational needs of patients’ families and primary care providers.
How would you rate your need for additional education about metabolic disorders for the care of patients
from birth to one year old?
 I do not have any additional education needs.
 I could use periodic updates about metabolic disorders and care practice.
 I would appreciate frequent updates about metabolic disorders and care practices.

72. What mode of education do you find most helpful?
 I prefer to research information myself on the web
 I prefer to have information mailed or emailed to me
 I prefer to receive information at conferences or professional meetings

Section 7: Wrap-Up
73. Thinking about the topics asked about here and any other concerns you have regarding the care of
children with metabolic disorders and their families during the first year of life, what is the greatest
challenge you face in practice?
__________________________________________________________________________________________
__________________________________________________________________________________________
_________________________________________________________________________________
74. What is the zip code of your primary practice location (for regional analyses only)? _______________
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Debriefing Sheet
Thank you for completing the survey! This page will further explain the purpose of the survey research you have just
participated in. After you are finished viewing this page and have submitted your answers by clicking on the button at
the bottom of the page, it is recommended you exit or quit your Web browser to eliminate the possibility (which varies
depending on your computer and browser) that your responses could be viewed by hitting the "back" button.
We would like to remind you that we will keep the information you provide confidential. Further, any potentially
identifying information (e.g., zip code) will be used only for regional analysis.
Because you have invested time in this study, you may have an interest in what we hope to find from your results. The
purpose of this study is to examine the process of care for patients diagnosed with metabolic conditions that detected
on newborn screen (NBS) from diagnosis to the first birthday. This study also examines the challenges and complexities
of providing care to these patients and their families.
If you have questions about this survey or would like a copy of the results when they are available, please email me or
call me at the number below.
Your participation, and that of your colleagues, is important for influencing ongoing policy discussions regarding the
importance of genetic medicine.
Thank you again for your interest and participation.
Principal Investigator: Robert J. McGrath
University of New Hampshire
Department of Health Management and Policy
327 Hewitt Hall
4 Library Way
Durham, NH 03824
Phone: 603-862-5047
Email: Robert.McGrath@unh.edu
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Appendix B. Methodology Report
This appendix contains a brief summary of the dates and modes of survey distribution through
participating organizations and networks as well as information on the final sample size.
Survey Distribution.
The survey was distributed to potential respondents in two phases. In the first stage,
participants were recruited via electronic contact through the Genetic Service and Newborn Screening
Regional Collaborative Groups (RCs). The RCs were able to contact members of their listserv and those
who received official RC newsletters. Some RCs decided to work with local provider organizations and
state NBS representatives in order to distribute the survey to the appropriate providers. Due to privacy
concerns, RCs did not want to share their provider lists with provider staff. Because of lackluster
response rates, a second stage of survey was employed. During this stage, an effort was made to recruit
providers directly through provider organizations, like the Society for the Inherited Metabolic Disorders
(SIMD) and the National Society of Genetic Counselors (NSGC). The method and dates of distribution
are indicated below.
Table Appendix B. Date and Method of Survey Distribution by Organization
Organization
Date
Method
10/18/11 (via New England Email to Consortium Planning Group
members
Consortium of Metabolic
New England Genetics
Programs)
Collaborative (NEGC)
10/28/2011

eNewsletter

10/6/2011

Email

1/20/2012

Email

Southeast NBS and Genetics
Collaborative (SERC)

1/9/2012

email

Region 4 Genetics Collaborative

10/17/2011

Email

Heartland Regional Genetics and
Newborn Screening Collaborative

12/7/2011

Email to providers in 8 states

1/10/2012

Email to additional providers

9/30/2011

Newsletter

10/19/2011

Email

11/30/2011

Newsletter

10/7/2011
11/15/2011
11/21/2011

Email to select group of providers
Email to providers contacted 10/7/11

New York-Mid-Atlantic Consortium
for Genetics and Newborn
Screening Services (NYMAC)

Mountain States Genetics Regional
Collaborative Center (MSGRCC)

Western States Genetic Services
Collaborative (WSGSC)

Email to regional dietitians and genetic
counselors
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National Coordinating Center for
the Regional Genetic and Newborn
Screening Service Collaboratives
(NCC)

12/16/2011

Newsletter

Pediatric and Clinical Genetics
special interest group listserv of
the National Society of Genetic
Counselors (NSGC)

1/20/2012

Listserv

NBS mailing list (Newborn
Screening Inquiry/Discussion List)
(NBS@lists.UTSCSA.edu)

1/23/2012

Listserv

Society for Inherited Metabolic
Disorders (SIMD)

2/8/2012

Email

American College of Medical
Genetics (ACMG) Annual Clinical
Genetics Meetings

3/27-31/12

Conference: flyer in conference bags,
survey on conference computers, booth

Genetic Metabolic Dietitians
International (GMDI) Educational
Conference

4/19-20, 2012

Conference: booth

Sample Size.
A total of 181 respondents viewed the survey. Of those 181, 35 reported no information on the
survey, 3 reported only one piece of information, and 5 reported 2 pieces of information. Because they
reported so little information, the decision was made to drop them from analyses. Additionally, 21
people who reported that they did not treat children diagnosed with metabolic conditions following a
positive newborn screen were also removed from the sample. Two additional cases were removed from
the sample because the respondents reported a zip code outside of the United States (Canada). The
final sample size of usable reports for this report is 114.
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Appendix C. Tables

Table 5. Challenges to Providing Care During the First Year of Life (n=84)

1

Very
Challenging
42.86 (36)

Somewhat
Challenging
51.19 (43)

Not Very
Challenging
4.76 (4)

Not At All
Challenging
-

Don't
Know/ Not
Available
-

Not
Reported
1.19 (1)

Parental/familial compliance with treatment and management
protocols
Language Barriers between Providers and Patients/Families

33.33 (28)

54.76 (46)

9.52 (8)

1.19 (1)

-

1.19 (1)

17.86 (15)

52.38 (44)

22.62 (19)

4.76 (4)

-

2.38 (2)

The Adequacy of Staffing at Your Clinic

17.86 (15)

35.71 (30)

33.33 (28)

8.33 (7)

1.19 (1)

3.57 (3)

Unique Protocols of Insurance Providers

35.71 (30)

41.67 (35)

13.10 (11)

1.19 (1)

4.76 (4)

3.57 (3)

Availability of Prescription Medications and/or Medical Foods

32.14 (27)

54.76 (46)

8.33 (7)

2.38 (2)

1.19 (1)

1.19 (1)

Ability to Transition Patients to Hospital Providers when they are
Admitted
Having to Take on Other Roles When Providing Care to
Patients/Families
Parent/Family Level of Knowledge and Awareness of their Child's
Disorder
Your Own Educational Needs Concerning Metabolic Disorders
Detected on NBS
Having Enough Time to Provide Patients/Families with All of the
Resources They Need
Lack of Reimbursement for All of the Care that Patients/Families
Need
Communication between the State NBS or Follow-Up Programs and
Providers
Primary Care Providers' Knowledge of Metabolic Disorders

4.76 (4)

27.38 (23)

46.43 (39)

15.48 (13)

4.76 (4)

1.19 (1)

13.10 (11)

52.38 (44)

26.19 (22)

7.14 (6)

1.19 (1)

-

17.86 (15)

64.29 (54)

15.48 (13)

2.38 (2)

-

-

5.95 (5)

28.57 (24)

38.10 (32)

23.81 (20)

2.38 (2)

1.19 (1)

40.48 (34)

44.05 (37)

11.90 (10)

2.38 (2)

1.19 (1)

-

61.90 (52)

27.38 (23)

4.76 (4)

1.19 (1)

3.57 (3)

1.19 (1)

3.57 (3)

15.48 (13)

35.71 (30)

41.67 (35)

2.38 (2)

1.19 (1)

25.00 (21)

47.62 (40)

22.62 (19)

1.19 (1)

2.38 (2)

1.19 (1)

Geographic Distance Between Providers and Patients/Families

1

Row percentages are shown.
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Table 7a. Metabolic Perceptions of Primary Care Providers Participation in Patient Care (n=84)

1

Strongly
Agree

Agree
Somewhat

Neither
Agree nor
Disagree

Disagree
Somewhat

Strongly
Disagree

Don't Know/
Not
Applicable

Not
Reported

44.05 (37)

28.57 (24)

16.67 (14)

8.33 (7)

-

1.19 (1)

1.19 (1)

59.52 (50)

34.52 (29)

3.57 (3)

-

-

1.19 (1)

1.19 (1)

39.29 (33)

25.00 (21)

15.48 (13)

14.29 (12)

1.19 (1)

2.38 (2)

2.38 (2)

11.90 (10)

20.24 (17)

30.95 (26)

25.00 (21)

5.95 (5)

4.76 (4)

1.19 (1)

21.43 (18)

38.10 (32)

9.52 (8)

20.24 (17)

4.76 (4)

-

5.95 (5)

Communication provides easy to utilize, factual information
about the child’s conditions, treatment, prognosis,
medications, and co-morbid conditions

33.33 (28)

46.43 (39)

9.52 (8)

5.95 (5)

1.19 (1)

1.19 (1)

2.38 (2)

Communication with primary care providers is a priority

47.62 (40)

34.52 (29)

7.14 (6)

3.57 (3)

-

-

7.14 (6)

General Perceptions
Primary care providers (PCPs) should participate on
metabolic patient care teams
PCPs often lack knowledge of the metabolic disorders
detected on uniform screening panel
PCPs should act as the medical home for metabolic patients
in the first year of life
PCPs should act as the liaison to the patient's insurance
company
Communication with PCPs
Communication occurs in both directions

1

Row percentages are shown.
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Table 7b. Effectiveness of Methods to Share Patient Management with Primary Care Providers (n=84)

1

Very
Effective
16.67(14)

Somewhat
Effective
42.86 (36)

Not Very
Effective
22.62 (19)

Not Effective
At All
2.38 (2)

Don't Know/
Not Applicable
13.10 (11)

Not
Reported
2.38 (2)

39.29 (33)

47.62 (40)

3.57 (3)

-

8.33 (7)

1.19 (1)

77.38 (65)

20.24 (17)

-

-

1.19 (1)

1.19 (1)

Consultation letter from the specialist describing findings,
actions taken, and plans
Condition-specific “fact sheet” with key information about the
condition
Shared or interoperable electronic health records

63.10 (53)

28.57 (24)

5.95 (5)

-

1.19 (1)

1.19 (1)

45.24 (38)

42.86 (36)

8.33 (7)

-

2.38 (2)

1.19 (1)

41.67 (35)

39.29 (33)

3.57 (3)

-

13.10 (11)

2.38 (2)

Regular email communication with primary care providers

23.81 (20)

47.62 (40)

14.29 (12)

1.19 (1)

11.90 (10)

1.19 (1)

Other

2.38 (2)

2.38 (2)

-

-

4.76 (4)

90.48 (76)

Periodic conference calls, including specialty and primary care
providers, parents, others
Active plan of care or action plan identifying current care needs,
who will provide action, and when the action should be
completed
Written emergency care plan

1

Row percentages are shown.
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Table 8. Attitudes Toward Expanding the NBS Panel (n=83)

1

Increasing the number of metabolic disorders on the NBS panel in
my state would increase my caseload
Expanding the number of metabolic conditions on the NBS panel
would increase the time I spend treating patients.
I may refer patients diagnosed with metabolic disorders added to
the NBS panel to specialists in those disorders.
I am concerned about being reimbursed for all of the care that I
would provide to patients diagnosed with a disorder on an
expanded NBS panel
There are not currently enough practitioners educated to care for
patients diagnosed with metabolic disorders on an expanded NBS
panel
I am concerned that there would not be evidence-based treatment
protocols to care for children diagnosed with disorders added to
the NBS panel
Adding disorders to the NBS panel will make working with parents
much more difficult
I am excited to think about being able to treat children with
metabolic diseases that would otherwise have not been detected
at birth
I am concerned that adding disorders to the NBS panel would
result in a greater number of false-positives

Strongly
Agree
60.24 (50)

Somewhat
Agree
32.53 (27)

Neither
Agree nor
Disagree
6.02 (5)

Somewhat
Disagree
-

Strongly
Disagree
-

Don't Know/
Not
Applicable
1.20 (1)

Not
Reported
-

54.22 (45)

32.53 (27)

9.64 (8)

1.20 (1)

-

1.20 (1)

1.20 (1)

15.66 (13)

14.46 (12)

20.48 (17)

15.66 (13)

19.28 (16)

14.46 (12)

-

40.96 (34)

27.71 (23)

13.25 (11)

2.41 (2)

4.82 (4)

10.84 (9)

-

62.65 (52)

19.28 (16)

14.46 (12)

2.41 (2)

-

-

1.20 (1)

40.96 (34)

30.12 (25)

14.46 (12)

12.05 (10)

1.20 (1)

-

1.20 (1)

6.02 (5)

13.25 (11)

30.12 (25)

24.10 (20)

22.89 (19)

1.20 (1)

2.41 (2)

44.58 (37)

30.12 (25)

16.87 (14)

6.02 (5)

-

1.20 (1)

1.20 (1)

32.53 (27)

31.33 (26)

18.07 (15)

8.43 (7)

6.02 (5)

2.41 (2)

1.20 (1)

1

Row percentages are shown.
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